PDF icon Mario SILVA
Prof.

SILVA Mario

Professore di II fascia
Dipartimento di Medicina e Chirurgia
Settore scientifico disciplinare
Diagnostica per immagini e radioterapia
  • Curriculum Vitae
  • Orario di ricevimento
  • Insegnamenti
  • Incarichi
  • Ricerca
  • Terza Missione
  • First name: Mario 
  • Last name: Silva
  • Born in Parma (Italy), 1983
  • Married, two daughters, one son

 EDUCATION Education in Medicine and Radiology

  1. 2002 – 2008 Medical School, graduation 110/110 “cum laude” at University of Parma (IT);
  2. 2007 – 2009 Internship in Radiology at the University of Parma (Chief Prof. M. Zompatori) (IT);
  3. 2009 Medical Board exam habilitation at University of Parma (IT);
  4. 2009 Medical License: Albo Provinciale dei Medici Chirurghi di PIACENZA (Ordine della Provincia di Piacenza) n. 0000002323;
  5. 2010 Course of Cardiac CT for Trainees: “IV Corso Residenziale di Cardio TC per Specializzandi”. Coordinator: Cademartiri F, MD, PhD. Azienda Ospedaliero-Universitaria di Parma (IT);
  6. 2011 – 2012 Trainee in Cardio-Vascular Imaging at the Diagnostic Imaging Department of Policlinico S. Orsola-Malpighi (Bologna, IT);
  7. 2009 – 2014 Trainee in Diagnostic Imaging School at the University of Parma (IT),
    graduated in Diagnostic Imaging in July 2014.

CLINICAL CAREER Clinical Expertise

Main expertise in Pulmonary, Cardiac, Vascular, Oncologic, and Emergency Imaging.

  • 2014 – present University Hospital of Parma.
  • 2014 – present Multidisciplinary Team of Thoracic Oncology at the University Hospital of Parma (weekly multidisciplinary discussion » 15-30 cases/week)

Clinical Certification

  • 2018-2025 Basic Life Support - Defibrillation (BLS-D) certificate according to America Heart Association (AHA - https://www.heart.org )
  • 2018-2024 Good Clinical Practice (GCP) certificate by the NIDA Clinical Trials Network (https://gcp.nidatraining.org )
  • 2019-2025 Advanced Cardiovascular Life Support (ACLS) certificate according to America Heart Association (AHA - https://www.heart.org )
  • April 2021 – October 2021 subscription and attendance at the “Master di Formazione per Direzione di UOC di Radiologia” issued by Società Italiana di Radiologia Medica (SIRM)
  • September 2021 – December 2021 – “Aggiornamento formative sulle esposizioni mediche – CORSO SIRM-AIFM-AIRM D.Lgs.101/20” issued by Società Italiana di Radiologia Medica (SIRM)
  • October 2021 – “Tutela della privacy in ambito sanitario” issued by Servizio Sanitario Regionale Emilia Romagna
  • November 2021 – “La trasparenza nella Pubblica Amministrazione” issued by Regione Emilia Romagna

ACADEMIC CAREER Fellowships

  • 2010 – 2023 Research Fellow in lung cancer screening trial at the Multicenter Italian Lung Detection (MILD and bioMILD), Fondazione IRCCS Istituto Nazionale Tumori (INT, Milan, Italy); 
  • 2013 Research Fellow in Cardiothoracic Imaging at Beth Israel Deaconess Medical Center (BIDMC, Harvard Medical School, Boston, MA, USA)
  • 2014 – 2018 Reading Radiologist in lung cancer screening at the MILD and bioMILD trials at Istituto Nazionale dei Tumori di Milano (screening low-dose computed tomography read: > 10,000).
  • 2020 – present Associate Researcher at the Institute for Diagnostic Accuracy Consulting B.V. (iDNA) in the field of lung cancer screening and early diagnosis of smoking related lung disease and cardiovascular risk factors

Academic positions

  • 2014-2017 – Doctorate in Surgical Sciences and Applied Microbiology at the University of Parma (IT). Date of PhD defense: March 15, 2017
  • 2015 – 2020 Assistant Professor at the University of Parma, Department of Surgical Sciences [RTD art. 24 lettera a), legge n. 240 del 30 dicembre 2010; SC 06/I1, SSD MED/36 Diagnostic Imaging and Radiation Therapy].
  • 2020 – present Vice President of the Degree course in IMAGING AND RADIOTHERAPY TECHNIQUES, University of Parma
  • 2021 – 2024 Assistant Professor at the University of Parma, Department of Surgical Sciences [RTD art. 24 lettera b), legge n. 240 del 30 dicembre 2010; SC 06/I1, SSD MED/36 Diagnostic Imaging and Radiation Therapy].
  • 2021 – Adjunct Assistant Professor at the University of Massachusetts, Department of Radiology in the TH Chan School of Medicine at the UMass Chan Medical School (Worcester, MA, USA). 
    URL: https://profiles.umassmed.edu/display/28136779
  • 2024 – Associate Professor at the University of Parma, Department of Surgical Sciences
    SC 06/I1, SSD MED/36 Diagnostic Imaging and Radiation Therapy

Academic Certifications

  • 2018 – Certification for Associate Professorship issued by the National Scientific Review Board (Abilitazione Scientifca Nazionale – ASN – alle funzioni di Professore Universitario di II Fascia, valida dal 02/10/2018 al 02/10/2024 art. 16, comma 1, Legge 240/10 – Official publication at https://asn16.cineca.it/pubblico/miur/esito-abilitato/06%252FI1/2/5 ).
  • 2022 – Certification for Full Professorship issued by the National Scientific Review Board (Abilitazione Scientifca Nazionale – ASN – alle funzioni di Professore Universitario di I Fascia, valida dal 07/06/2022 al 07/06/2032 art. 16, comma 1, Legge 240/10 – Official publication at https://asn21.cineca.it/pubblico/miur/esito/06%252FI1/1/2 ) – See “Attachment 1”.

Teaching Assignments

  • 2016 – present Chief of teaching course and Official teaching Assignment: Operating Protocols Magnetic Resonance And Computed Tomography; Degree Course In Imaging And Radiotherapy Techniques, University Of Parma
  • 2017 – present Residency Program in Diagnostic Imaging at the University of Parma
  • 2017 – present Official teaching Assignment: Diagnostics Of Images And Radiology; Master Degree In Medical School, University of Parma
  • 2018 – present Official teaching Assignment: Diagnostics Of Images And Radiology; Master Degree In Dentist School, University of Parma

Academic Activity

  • Students and trainees mentoring 
  • Responsibility of degree thesis for:
    • Master Degree in Medical School
    • Degree course in Imaging And Radiotherapy Techniques
    • Residency Program in Diagnostic Imaging
  • Manager of International exchange program at the Section of Radiology, Department of Medicine and Surgery (DiMeC) at the Univeristy of Parma:
    • 2019 Visiting Professor: Sundeep M Nayak, MD, Senior Physician, The Permanente Medical Group, Inc. – San Leandro, California
  • Committee member and Secretariat in Academic job competions for research positions, including post-doc positions:
    • Role: Secretary
      Selection: Procedura di selezione pubblica, per titoli e colloquio, indetta con decreto rettorale rep drd n. 309/2018, prot. 27097 in data 09/02/2018, per il conferimento di n. 1 assegno di ricerca di durata 24 mesi avente per argomento ”Micro-tomografia computerizzata nello sviluppo dei farmaci: un metodo non invasivo per valutare la progression di malattia”, per il s.s.d. MED/36 “Diagnostica per immagini e radioterapia” presso il Dipartimento di Medicina e Chirurgia dell'Università di Parma, ai sensi dell’art. 22 della legge 240/2010
    • Role: Secretary
      Selection: Procedura di selezione pubblica, per titoli e colloquio, indetta con decreto rettorale rep. drd n. 462/2020 prot. 93856 del 26.05.2020, per il conferimento di n. 1 assegno di ricerca di durata 24 mesi avente per argomento ”Micro-tomografia computerizzata nello sviluppo dei farmaci: un metodo non invasivo per valutare la progressione di malattia”, per il s.s.d. MED/36 “Diagnostica per immagini e radioterapia” presso il Dipartimento di Medicina e Chirurgia dell'Università di Parma, ai sensi dell’art. 22 della legge 240/2010
    • Role: Secretary
      Selection: Bando per conferimento di contratto di diritto private a titolo gratuito a dirigenti medici per la Scuola di Specializzazione in Radiodiagnostica dell’Università di Parma per l’anno accadmeico 2019/2020, ai sensi del DM. n. 68 del 4 febbraio 2015
  • Invited Faculty:
  • University of Padova, Italy – Host Faculty: Prof. Paolo Spagnolo
    Residency Program in Pulmonology. Symposium: “Lung cancer screening and clinical management of lung nodule”. December 20, 2019 – Padova (IT).
    • University of Massachusetts Medical Center and University of Massachusetts Medical School, Massachusetts (USA) – Host Faculty: Prof. Max Rosen and Prof. Alexander Bankier
      • 13th Annual Edward Smith Lecture “Living through Covid -19 in Northern Italy – views from a radiologist, physician, and citizen”. June 10, 2020 – Online and Worcester (MA)
      • Residency Program in Radiology “Difficulties in ILD imaging: IPF vs CHP”. November 20, 2020 – Online and Worcester (MA)
  • University of Piemonte Orientale, Italy – Host Faculty: Prof. Alessandro Carriero
    Italian Network of Residency Program in Radiology. Symposium: “La dispnea”. March 8, 2022 – Online National Streaming.
  • University of Modena and Reggio Emilia, Italy – Host Faculty: Prof. Guido Ligabue
    Residency Program in Radiology. Symposium: “Semeiotica del nodulo polmonare”. March 13, 2023 – Modena (IT).
  • University of Piemonte Orientale, Italy – Host Faculty: Prof. Alessandro Carriero
    Italian Network of Residency Program in Radiology. Symposium: “Tumore polmonare: semeiotica imaging del paziente con malattia avanzata”. March 15, 2023 – Online National Streaming.
  • National Doctorate:
    • Alma Mater Studiorum – Università di Bologna
      Dottorato di Ricerca in Oncologia, Ematologia e Patologia (XXXVI Ciclo)
      Title: “A machine learning approach to identify patients with resected non-small-cell lung cancer with high risk of relapse”
      Candidate: Andrea Prochowski Iamurri 
      Role:       Reviewer (2023)
       
  • International Doctorate:
    • University of Groningen, The Netherlands
      Candidate: Sunyi Zheng 
      Role:       Opposition committee in PhD Defense (June 22, 2021)
       

Awards

  1. 2014 RSNA Introduction to Research for International Young Academics (IRIYA) Program, sponsored by the Committee on International Radiology Education (CIRE).
  2. 2015 The Outstanding Young Person (TOYP) Prize in Category “Research” organized by the Junior Chamber International (JCI), Parma Section, Italy.
  3. 2015 “Premio Luigi Pigorini” National award to proficient scientific production in Thoracic Imaging, for Radiologists under the age of 40 – Società Italiana di Radiologia medica (SIRM), Section of Thoracic Imaging.
  4. 2017 European Congress of Radiology (ECR 2017, March 1-5 – Vienna, Austria): Best Scientific Paper Presentation Award 2017 within the topic "Chest"

Awarded presentation: “Subsolid and Part-Solid Nodules in Lung Cancer Screening: Comparison Between Visual and Computer-Aided Detection” Silva M, Capretti G, Sverzellati N, Jacobs J, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Marchianò A, Pastorino U.

  1. 2017 54th National Congress of the Italian Society of Rheumatology (SIR – November 22-25, Rimini, Italy) Awarded poster: “Quantification of Interstitial Lung Disease in Sjogren Syndrome” Ariani A, Silva M, Martin Garrido, Martin Segarra O, Santilli D, Mozzani F, Luque Pinilla JM, Sverzellati N, Guisado Vasco P.
  2. 2017 Journal of Thoracic Imaging’ (JTI) Editor’s Recognition Award for Distinction in Reviewing in 2017, as noted in the January 2018 issue of the journal.
  3. 2018 Journal of Thoracic Imaging’ (JTI) Editor’s Recognition Award for Distinction in Reviewing in 2018, as noted in the January 2019 issue of the journal.

SCIENTIFIC ACTIVITY

Scopus Author ID: 56335785800 http://www.scopus.com/authid/detail.uri?authorId=56335785800

Web of Science ResearcherID: B-9509-2016  http://www.researcherid.com/rid/B-9509-2016

ORCID: 0000-0002-2538-7032 http://orcid.org/0000-0002-2538-7032

ResearchGate: https://www.researchgate.net/profile/Mario_Silva12/

Google Scholar: http://scholar.google.it/citations?user=gzM0B_QAAAAJ&hl=en

National And International Scientific Collaborations

  1. 2010 – 2023  Fondazione IRCCS Istituto Nazionale dei Tumori (INT) – Milan, Italy
  2. 2014 – 2016  Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School – Boston (MA), Unites States of America
  3. 2014 – 2023  Radboud University Medical Center – Nijmegen, The Netherlands
  4. 2017-2019 University of Brescia – Brescia, Italy
  5. 2018 – ongoing  Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF), Faculty of Medicine and Health, The University of Sydney, Royal Prince Alfred Hospital – Camperdown, Australia
  6. 2020 – present Institute for Diagnostic Accuracy Consulting B.V. (iDNA) awarded an EU project (4-in-the-lung-run) in the field of lung cancer screening and early diagnosis of smoking related lung disease and cardiovascular risk factors
  7. 2021 – present University of Twente (The Netherlands) leading the multicenter project “Preference study for Big-3 Screening”

Grants

  1. 2016 – ESTI Experienced Chest Radiology Researchers Grant – European Society of Thoracic Imaging (ESTI).
    Project title: “Information From Computed Tomography Follow-Up in Idiopathic Pulmonary Fibrosis: iPFBC Multicenter Pooled Comparison With Clinical and Functional Metrics”
    Role: Principal Investigator
    Funding: 7,500 euros
  2. 2019 – Italian Foundation for Cancer Research (Associazione Italiana per la Ricerca sul Cancro, AIRC) Investigator Grant - IG 2019
    Project title: “A Radio-Immuno-Genomic Approach to Identify Prognostic and Predictive Models for the Response to Immunotherapy in NSCLC” – PI: Prof. Nicola Sverzellati (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Grant ID: 23606
    Role: Experienced researcher
    Funding: 1,119,000 euros
  3. 2019 – Fondazione Cariparma
    Project title: “Progetto Salute Parma (PSP): Prevenzione Primaria e Secondaria del Danno da Fumo” (Primary and Secondary Prevention (PSP) of Smoking Related Damage: Parma Project) – PI: Prof. Nicola Sverzellati (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Grant ID: 0166/2019
    Role: Scientific collaborator
    Funding: 139,000 euros
  4. 2020 – University of Parma “Bando straordinario di Ateneo per progetti di ricerca biomedica in ambito SARS-CoV-2 e COVID-19”
    Project title: “Morbilità e mortalità da Covid-19 nel diabete mellito di tipo 2: possibile ruolo del macrofago e impatto di farmaci anti-diabete” – PI: Prof. Riccardo Bonadonna (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Role: Scientific collaborator
  5. 2020 – Swiss National Science Foundation (SNSF), National Research Programme (NRP) 78 entitled “COVID-19”
    Project title: “AI-multi-omics-based Prognostic Stratification of COVID-19 Patients in Acute and Chronic State” – PI: Alexander Pollinger (Inselspital Bern, University of Bern, Bern, Switzerland)
    Role: Scientific collaborator
    Funding: 617,665 CHF
  6. 2020 – Italian Ministry of Health, BANDO RICERCA FINALIZZATA 2019 
    Project title: “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth (PEOPLHE)” – PI: Prof. Nicola Sverzellati (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Role: Research team
    Funding: 449,940 euro
  7. 2022 – Italian Ministry of Health, BANDO RICERCA FINALIZZATA 2021 – Young Researchers Under 40
    Project title: “A new diagnostic algorithm to non-invasively track fibrotic changes in myeloproliferative neoplasms based on C-C Chemokine Receptor 2 detection. From flow cytometry to the development of targeted Positron Emission Tomography molecular imaging. Pre-clinical studies and first in-human proof of concept” – PI: Prof. Elena Masselli
    (Department of Medicine and Surgery, University of Parma, Parma, Italy)
    Role: Collaborator
    Funding:     430,000 euro (GR-2021-12373308)

Clinical TrialsLung Cancer Screening by Low-Dose Computed Tomography

  1. MILD: Multicentric Italian Lung Detection (ClinicalTrials.gov Identifier: NCT02837809)
  2. bioMILD:  Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study (ClinicalTrials.gov Identifier: NCT02247453)
  3. SMILE: Screening and Multiple Intervention on Lung Epidemics (ClinicalTrials.gov Identifier: NCT03654105)
  1. PSP: Progetto Salute Parma: Prevenzione Primaria e Secondaria del Danno da Fumo (Primary and Secondary Prevention (PSP) of Smoking Related Damage: Parma Project) (ClinicalTrials.gov Identifier: NCT04282694)
  2. PEOPLHE: Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth
  3. RISP: Rete Italiana Screening Polmone
  4. 4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening 
    Funded in HORIZON 2020 (7,999,948.75 euro, Grant agreement ID: 848294)
    url: https://cordis.europa.eu/project/id/848294

Thoracic Oncology

  1. EORTC (European Organisation for Research and Treatment of Cancer) Lung Cancer Group)
    1. Study 1417: “REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer”
      (EudraCT number:  2014-003090-42) 
    2. Study 1613: “APPLE: Feasibility and activity of AZD9291 treatment on Positive PLasma T790M in EGFR mutant NSCLC patients”
      (EudraCT number: 2016-001834-82)
    3. Study 1525: “Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemotherapy – Nivothym”
      (EudraCT number: 2015-005504-28)
  2. PARMA: Progetto AIRC Ricerca Multiomica Avanzata (A Radio-Immuno-Genomic Approach to Identify Prognostic and Predictive Models for the Response to Immunotherapy in NSCLC) (ClinicalTrials.gov registration underway)

Oncoheamatology 

  1. ACE-CL-007: Elevate CLL TN: Study of Obinutuzumab + Chlorambucil, Acalabrutinib (ACP-196) + Obinutuzumab, and Acalabrutinib in Subjects With Previously Untreated CLL (ClinicalTrials.gov Identifier: NCT02475681)
  2. ACE-LY-308: A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma (ClinicalTrials.gov Identifier: NCT02972840)
  3. 20130109: Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab (JASMINE) (ClinicalTrials.gov Identifier: NCT02747043)
  4. CC-5013-NHL-007: Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) (AUGMENT) (ClinicalTrials.gov Identifier: NCT01938001)
  5. GS-US-313-1580: Dose Optimization Study of Idelalisib in Follicular Lymphoma (ClinicalTrials.gov Identifier: NCT02536300)
  6. B-MIND: A Trial to Evaluate the Efficacy and Safety of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (ClinicalTrials.gov Identifier: NCT02763319)
  7. PCYC-1141-CA: Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma (ClinicalTrials.gov Identifier: NCT02947347)
  8. B3281006: A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) (ClinicalTrials.gov Identifier: NCT02213263)

Development Of Quantitative Imaging And Artificial Intelligence

  1. 2013 – 2016 Pulmo3D and Airway Examiner, MeVis - Fraunhofer, Germany
  2. 2013 – 2016 Parametric Response Map (PRM) for COPD phenotyping, Imbio - Minneapolis, MN
  3. 2013 – present Quantitative Imaging Biomarkers Alliance (QIBA), Committee “QIBA Lung Density Biomarker” http://qibawiki.rsna.org/index.php/Lung_Density_Biomarker_Ctte
  4. 2014 – 2018 CIRRUS Lung Screening, CAD system for detection and quantification of lung nodules – Radboud University Medical Center, Nijmegen, Netherlands
  5. 2014 – 2015 OraMod European project, Mutidisciplinary platform for comprehensive management of oral cancer “Imaging platform for quantitative analysis and standardized staging” – Imaging developers the Fraunhofer Institute for Computer Graphics IGD in Darmstadt (DE) and the Univeristy of Parma (IT).
    Grant agreement ID: 611425
  6. 2016 – 2019 BD2Decide project: A Prospective Observational Study for the Development and Validation of New Prognostic Models in Head and Neck Cancer Patients for Decision Support. 
    European Commission funded projects within the program “Horizon2020”, accessible within the Community Research and Development Information Servive (CORDIS): http://cordis.europa.eu/project/rcn/200298_en.html 
    H2020-PHC-2015-689715 BD2Decide
    Grant agreement ID: 689715
  7. 2017 – present Quantitative Imaging Biomarkers Alliance (QIBA), Commitee  “CT Small Lung Nodule Biomarker” http://qibawiki.rsna.org/index.php/CT_Small_Lung_Nodule_Biomarker_Ctte
  8. 2020 – present Institute for Diagnostic Accuracy Consulting B.V. (iDNA) awarded an EU project (4-in-the-lung-run) in the field of lung cancer screening and early diagnosis of smoking related lung disease and cardiovascular risk factors.

Membership Of Scientific Societies

  1. Ordinary member of the Italian Society of Radiology (SIRM), Sections of Thoracic Imaging and Cardiovascular Imaging, since 2009
  2. Elected delegate of “Young Radiologists” for the Regional Group of SIRM in Emilia-Romagna 2012-2013
  3. Ordinary member of the European Society of Radiology since 2012 
  4. Ordinary member of the European Society of Thoracic Imaging (ESTI) since 2012 
  5. Junior member of the Radiology Society of North America (RSNA) since 2013
  6. Ordinary member of Quantitative Imaging Biomarkers Alliance (QIBA) “COPD/Asthma” and “Lung Nodule assessment in CT screening” section at RSNA since 2013, and “CT Small Lung Nodule Biomarker Ctte” since 2018
  7. Silver Under 35 member of European Respiratory Society (ERS) since 2014
  8. European Organization for Reasearch and Treatment of Cancer (EORTC – Lung Section) since 2015
  9. Board member of the European Society of Thoracic Imaging (ESTI) since 2017
  10. International Association for the Study of Lung Cancer (IASLC) since 2021
  11. Elected delegate of “University Radiologists” for the Regional Group of SIRM in Emilia-Romagna 2025-2026

Membership Of International Scientific Committees

  1. European Society of Thoracic Imaging (ESTI): 
    1. Member of the “Social Media Committee” (formerly “Electronic Media Committee”) (http://esti.gr4fix.net/committee/) 2017-2025
    2. Lung cancer screening (LCS) certification project since 2019
      URL: https://www.myesti.org/lungcancerscreeningcertificationproject/
    3. European Society of Thoracic Imaging (ESTI) representative (aka: Subspecialty Society Delegate) in the European Society of Radiology (ESR) Research Committee since 2020
    4. Member of the “Training and Educational Committee - LCS” in the Section
      1. “Structured report” (http://esti.gr4fix.net/committee/) 2020-2023
      2. “CAD Workshops” (http://www.myesti.org/committee/) 2022-2025
  2. European Society of Radiology (ESR): e-Learning committee “Chest Imaging” (role: Content lead) since 2018.

International Guidelines Committee

1.     European Society of Radiology (ESR) and European Respitatory Society (ERS) white paper on Lung Cancer Screening. Chapters assigned: 

  1. Italian experience: Bonomo L, Silva M
  2. Overdiagnosis: Silva M, Brodersen J, Gaga M, Bostantzoglou N, Revel MP
  3. Biomarkers for lung cancer: Silva M, Blum T, Peled N, Gaga M
  1. European Task Force: TF-2020-10 ERS/ESTI/ESR/ESTRO/ESTS Clinical Practice Guideline on the management of positive findings from low-dose CT screening for lung cancer

Editor For International Scientific Journals

1.     European Journal of Radiology (ISSN: 0720-048X):

a.     Section Editor of “Chest Imaging” since 2018 (impact factor 2.462)

b.     Lead Editor of Section “Chest Imaging” since 2021 (impact factor 2.687)
URL: https://www.ejradiology.com/content/edboard

2.     Tumori Journal (ISSN: 0300-8916): Section Editor of “Imaging Section” since 2019 (impact factor 1.304) – URL: https://journals.sagepub.com/editorial-board/tmj

3.     British Journal of Radiology (ISSN: 0007-1285): Associate Editor of “Respiratory/Chest Diagnostics” since 2020 (impact factor 1.939) – URL: https://www.birpublications.org/page/editorialboard/bjr 
 

Reviewer For International Authorities

1.     Appointed peer reviewer by Cancer Research UK ( https://www.cancerresearchuk.org ), for the specific task of Early Detection Research Committee:

a.     Application Title: “ASCENT: Analysis of screen-detected lung cancers genomic traits”
Application Reference: C9429/A28706

2.     Interface Politikstudien Forschung Beratung GmbH ( https://www.interface-pol.ch/en ): appointed as “Italian expert” in International survey for planning of Lung Cancer Screening at population level in Switzerland

 Reviewer For International Scientific Journals (selection)

  1. “Respiration” (ISSN: 0025-7931) since 2013 (impact factor 2.651);
  2. “COPD: Journal Of Chronic Obstructive Pulmonary Disease” (ISSN: 1541-2555) since 2013 (impact factor 2.673);
  3. “BMC Musculoskeletal Disorders” (ISSN: 1471-2474) since 2014 (impact factor 1.941);
  4. “Chest” (Print ISSN: 0012-3692; Online ISSN: 1931-3543) since 2014 (impact factor 5.94);
  5. “Journal of Thoracic Imaging” (Print ISSN: 0883-5993; Online ISSN: 1536-0237) since 2014 (impact factor 1.723);
  6. “Tumori Journal” (ISSN: 0300-8916) since 2015 (impact factor 1.071);
  7. “Cancer Imaging” (ISSN: 1470-7330) since 2015 (impact factor 1.470);
  8. “European Radiology” (Print ISSN: 0938-7994; Online ISSN: 1432-1084) since 2015 (impact factor 3.640);
  9. “QJM: an International Journal of Medicine” (Print ISSN 1460-2725; Online ISSN 1460-2393) since 2015 (impact factor 2.634);
  10. “Eurorad” brought by the European Society of Radiology ( https://www.eurorad.org/about-us ) since 2016.
  11. “Acta Radiologica” (Print ISSN: 0284-1851; Online ISSN: 1600- 0455) since 2016 (impact factor 2.009);
  12. “BMC Pulmonary Medicine” (ISSN: 1471-2466) since 2017 (impact factor 2.329);
  13. “European Journal of Radiology” (ISSN: 0720-048X) since 2017 (impact factor 2.462);
  14. “Investigative Radiology” (ISSN: 0020-9996; Online ISSN: 1536-0210) since 2018 (impact factor 5.195);
  15. “International Journal of Tuberculosis and Lung Disease (IJTLD)” (ISSN: 1027-3719; Online ISSN: 1815-7920) since 2018 (impact factor 2.468);
  16. “British Medical Journal Open (BMJ Open)” (Online ISSN: 2044-6055) since 2018 (impact factor 2.413);
  17. “European Respiratory Journal (ERJ)” (ISSN: 0903-1936; Online ISSN: 1399-3003) since 2018 (impact factor 12.242). 
  18. “Lung Cancer” (ISSN: 0169-5002) since 2019 (impact factor 4.486).
  19. “British Journal of Radiology” (ISSN: 0007-1285) since 2019 (impact factor 2.050).
  20. “Respiratory Medicine” (ISSN: 0954-6111) since 2019 (impact factor 3.230).
  21. “Radiology” (ISSN: 0033-8419) since 2019 (impact factor 7.469).
  22. “BMC Cancer Communications” (ISSN: 2523-3548) since 2019 (impact factor 3.644).
  23. “Cancer epidemics” (ISSN: 1877-7821) since 2019 (impact factor 2.619).
  24. “American Journal of Respiratory and Critical Care Medicine – AJRCCM” (ISSN: 1073-449X; Online ISSN: 1535-4970) since 2019 (impact factor: 16.494).
  25. “Academic Radiology” (ISSN: 1878-4046) since 2019 (impact factor: 2.267).
  26. “BMC Family Practice” (ISSN‎: ‎1471-2296) since 2019 (impact factor: 2.666).
  27. “Respirator Reaserch” (ISSN:  1465-993X) since 2019 (IF: 3.829).
  28. “The Lancet Digital Health” (ISSN: 2589-7500) since 2020.
  29. “BMC Infectious disease” (ISSN: 1471-2334) since 2020 (IF: 2.580).
  30. “Annals of Oncology” (ISSN: 0923-7534) since 2020 (IF: 18.274).
  31. “Cancers” (ISSN: 2072-6694) since 2021 (IF: 6.126)
  32. “Respiratory Investigation” (ISSN: 2212-5345) since 2021 (IF: 1.64)
  33. “The Lancet Oncology” (ISSN: 1470-2045 – eISSN: 1474-5488) since 2022 (IF: 41.316)
  34. “The Lancet Respiratory Medicine” (ISSN: 2213-2600) since 2023 (IF: 102.642)

Editor Of Book

  1. Cancer Dissemination Pathways (Series ISSN 2510-3474): The Thorax (1st ed. 2020 Edition) – Sverzellati N, Silva M Editors (Springer; eBook ISBN 978-3-030-27233-3; hardcover ISBN 978-3-030-27232-6) https://www.springer.com/gp/book/9783030272326

Author Of Book Chapters

  1. Radiologia Medica collections 2010 – Corso Monotematico di radiologia Toracica
    Authors: Sverzellati N, Silva M, Zompatori M. Chapter: BOOP and other interstitial lung diseases.
  2. Patologia Toracica di Interesse Chirurgico - Monte Università Parma Editore 2011 – Parma – Italia – IMAGING DELLA PATOLOGIA NEOPLASTICA DEL TORACE 
    Authors: Di Lauro E, Silva M, Rossi C, Buttarelli L, Sverzellati N.
  3. Atlas of Diffuse Lung Diseases – A Multidisciplinary Approach – Dalpiaz G, Cancellieri A Editors (Springer; ISBN 3319427504) – Chapters “Septal Disease” and “Nodular Disease” 
    Authors: Sverzellati N, Silva M
  4. Bronchiectasis. The EMBARC Manual – Chalmers JD, Polverino E, Aliberti S Editors (Springer; ISBN 978-3-319-61451-9; ISBN e-book: 978-3-319-61452-6) https://doi.org/10.1007/978-3-319-61452-6 – Chapter “Imaging of Bronchiectasis” 
    Authors: Silva M, Milanese G, Sverzellati N. 
  5. ESC Textbook of Cardiovascular Medicine 3rd edition (2019) – Luscher T, Camm J, Maurer G, Serruys P Editors (Oxfor University Press) – Section 009: Chest radiography, Chapter “Focal abnormalities” Authors: Milanese G, Silva M, Sverzellati N.
  6. Cancer Dissemination Pathways (Series ISSN 2510-3474): The Thorax (1st ed. 2020 Edition) – Sverzellati N, Silva M Editors (Springer; eBook ISBN 978-3-030-27233-3; hardcover ISBN 978-3-030-27232-6)https://www.springer.com/gp/book/9783030272326
    1. Chapter 2: “Radiological Signs of Tumor Dissemination” – Authors: Beer L, Oberndorfer F, Silva M, Prosch H
    2. Chapter 7: “Other Mediastinal Tumors” – Authors: Milone F, Taronna G, Gnetti L, Silva M
  7. Grainger & Allison's Diagnostic Radiology 7th Edition (Elsevier; Hardcover ISBN 9780702075247; eBook ISBN 9780702075612– 9780702075629) – Adam A, Dixon A, Gillard J, Schaefer-Prokop CM Editors (2020) – Section “Chest and Cardiovascular System”, Chapter 9 “High-Resolution Computed Tomography of Interstitial and Occupational Lung Disease” – Authors Silva M, Sverzellati N
  8. Malattie dell’apparato respiratorio – Pneumologia e Chirurgia Toracica 2nd Edition (ISBN-13 978-8855320542) – Loizzi M, Oliaro A. Ed. Minerva Medica (2021) – Chapter “La TC del torace nello screening del tumore polmonare”
    Authors: Cardianle L, Stranieri G, Chiado’ A, Silva M
  9. Artificial Intelligence in Cardiothoracic Imaging (ISBN-13 978-3030920869) – De Cecco CN, van Assen M, Leiner T. Editors (2022) – Chapter “Artificial Intelligence-Based Evaluation of Patients with Interstitial Lung Disease”
    Authors: Silva M, Milanese G, Ledda RE, Maddalo M, Sverzellati N.
  10. Imaging in Geriatrics (ISBN 978-3-031-14877-4) – Guglielmi G, Maas M. Editors (2023) – Chapter “Airway Diseases in Geriatric Patients” 
    Authors: Balbi M, Ledda RE, Pamparino S, Milanese G, Silva M, Sverzellati N.

 

 

PubMed link: https://www.ncbi.nlm.nih.gov/sites/myncbi/1nEPeKtxjp95V/bibliography/47785154/public/?sort=date&direction=ascending

h-index: 29 (source: Scopus https://www.scopus.com/authid/detail.uri?authorId=56335785800 )

Documents: 135

Citations: 3,234

January 22, 2024

 

  1. Silva M, Sverzellati N, Manna C, Negrini G, Marchianò A, Zompatori M, Rossi C, Pastorino U. Long-term surveillance of ground-glass nodules: evidence from the MILD trial. J Thorac Oncol. 2012 Oct;7(10):1541-6. 
    doi: 10.1097/JTO.0b013e3182641bba
  2. De Filippo M, Castagna A, Steinbach SL, Silva M, Concari G, Pedrazzi G, Pogliacomi F, Sverzellati N, Petriccioli D, Vitale M, Ceccarelli F, Zompatori M, Rossi C. Reproducible Noninvasive Method for Evaluation of Glenoid Bone Loss by Multiplanar Reconstruction Curved Computed Tomographic Imaging Using a Cadaveric Model. Arthroscopy. 2013 Mar;29(3):471-7. 
    doi: 10.1016/j.arthro.2012.10.017
  3. Sverzellati N, Randi G, Spagnolo P, Marchianò A, Silva M, Kuhnigk JM, La Vecchia C, Zompatori M, Pastorino U. Increased mean lung density: Another independent predictor of lung cancer? Eur J Radiol. 2013 Aug;82(8):1325-31. 
    doi: 10.1016/j.ejrad.2013.01.020
  4. Sverzellati N, Colombi D, Randi G, Pavarani A, Silva M, Walsh SL, Pistolesi M, Alfieri V, Chetta A, Vaccarezza M, Vitale M, Pastorino U. Computed tomography measurement of rib cage morphometry in emphysema. PLoS One. 2013 Jul 31;8(7):e68546. 
    doi: 10.1371/journal.pone.0068546
  5. Colombi D, Di Lauro E, Silva M, Manna C, Rossi C, De Filippo M, Zompatori M, Ruffini L, Sverzellati N. Non-small cell lung cancer after surgery and chemoradiotherapy: follow-up and response assessment. Diagn Interv Radiol. 2013 Nov-Dec;19(6):447-56.
    doi: 10.5152/dir.2013.12021
  6. Ariozzi I, Paladini L, Gnetti L, Silva M, Colombi D, De Filippo M, Sverzellati N. Computed tomography-histologic correlations in lung cancer. Pathologica 2013 Dec; 105(6):329-36. Review. 
    PMID: 24730336
  7. Litmanovich D, Hartwick K, Silva M, Bankier AA.  Multidetector CT imaging in COPD: emphysema and airways assessment. Radiol Clin North Am. 2014 Jan;52(1):137-54. 
    doi:10.1016/j.rcl.2013.09.002
  8. Shahrzad M, Le TSM, Silva M, Bankier AA, Eisenberg RL. Anterior mediastinal masses. AJR Am J Roentgenol. 2014 Aug;203(2):W128-38. 
    doi: 10.2214/AJR.13.11998
  9. De Filippo M, Saba L, Silva M, Zagaria R, Concari G, Nizzoli R, Bozzetti C, Tiseo M, Ardizzoni A, Lipia S, Paladini I, Macarini L, Carrafiello G, Brunese L, Rotondo A, Rossi C. CT-guided biopsy of pulmonary nodule: is pulmonary hemorrhage a complication or an advantage? Diagn Interv Radiol 2014. 
    doi: 10.5152/dir.2014.14019
  10. Silva M, Sabato M, Valentino M, Murrone S and Sverzellati N (2014) Unusual Findings of Langerhans Cell Histocytosis in a Young Asymptomatic Patient: Case Report. J Pulm Respir Med 4:188. 
    doi: 10.4172/2161-105X.1000188 Not indexed in PubMed
  11. Ariani A, Lumetti F, Silva M, Santilli D, Mozzani F, Delsante G, Sverzellati N. Systemic sclerosis interstitial lung disease evaluation: comparison between semiquantitative and quantitative CT assessments. J Biol Regul Homeost Agents. 2014 Jul-Sep;28(3):507-13. 
    PMID: 25316138
  12. Nemec SF, Molinari F, Dufresne V, Gosset N, Silva M, Bankier AA. Comparison of Four Software Packages for CT Lung Volumetry in Healthy Individuals. Eur Radiol. 2015 Jun;25(6):1588-97. 
    doi: 10.1007/s00330-014-3557-3
  13. Pastorino U, Silva M.  Refining Strategies to Identify Populations to Be Screened for Lung Cancer. Thoracic Surgery Clinics. Published Online: February 17, 2015. 
    doi: 10.1016/j.thorsurg.2014.11.005
  14. Silva M, Nunes H, Valeyre D, Sverzellati N. Imaging of Sarcoidosis. Clin Rev Allergy Immunol. 2015 Aug;49(1):45-53. 
    doi: 10.1007/s12016-015-8478-7
  15. Ariani A, Silva M, Bravi E, Saracco M, Parisi S, De Gennaro F, Lumetti F, Idolazzi L, Seletti V, Caramaschi P, Benini C, Bodini FC, Scirè CA, Lucchini G, Santilli D, Mozzani F, Imberti D, Arrigoni E, Delsante G, Pellerito R, Fusaro E, Sverzellati N. Operator-independent Quantitative Chest Computed Tomography Versus Standard Assessment of Interstitial Lung Disease related to Systemic Sclerosis: a Multi-Centric Study. Mod Rheumatol. 2015 Sep;25(5):724-30. 
    doi: 10.3109/14397595.2015.1016200
  16. DuBrock HM, Bankier AA, Silva M, Litmanovich DE, Curry MP, Washko GR. Pulmonary vessel cross-sectional area before and after liver transplantation: quantification with computed tomography. Acad Radiol. 2015 Jun;22(6):752-9. 
    doi: 10.1016/j.acra.2015.01.018
  17. Colombi D, Manna C, Montermini I, Seletti V, Diciotti S, Tiseo M, Fontana E, De Filippo M, Silva M, Sverzellati N. Semiautomatic Analysis on CT scan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Reproducibility and Prognostic Significance of Uni-dimensional and Three-Dimensional Measurements. J Thorac Imaging. 2015 Sep;30(5):290-9. 
    doi: 10.1097/RTI.0000000000000145
  18. De Filippo M, Saba L, Negrini G, Silva M, Pedrazzi G, Pogliacomi F, Castagna A. Inter-observer agreement of CT measurement of the glenoid bone surface by the CT Pico method: Comparison with laser in a cadaveric model. Skeletal Radiol. 2015 Oct;44(10):1491-7. 
    doi: 10.1007/s00256-015-2199-0
  19. Silva M, Bankier AA, Centra F, Colombi D, Ampollini L, Carbognani P, Sverzellati N. Longitudinal Evolution of Incidentally Detected Solitary Pure Ground-Glass Nodules on CT: Relation to Clinical Metrics. Diagn Interv Radiol (Ank). 2015 Jul 3. 
    doi: 10.5152/dir.2015.14457
  20. Walsh SLF , Calandriello L, Sverzellati N, Hansell DM on behalf of The UIP Observer Consort (Collaborators include Silva M). Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT. Thorax 2015;0:1–7. 
    doi: 10.1136/thoraxjnl-2015-207252.
  21. Lumetti F, Barone L, Alfieri C, Silva M, Serra V, Delsante G, Sverzellati N, Ariani A. Quality of Life and Functional Disability in Patients with Interstitial Lung Disease Related to Systemic Sclerosis. Acta Biomed. 2015 Sep 14;86(2):142-8. 
    PMID: 26422428
  22. Silva M, Nemec S, Dufresne V, Occhipinti M, Heidinger B, Chamberlain R, Bankier AA. Normal Spectrum of Pulmonary Response Map: Distribution of Densitometric Classifications in Healthy Adult Volunteers. Eur Radiol. 2016 Sep;26(9):3063-70.
    doi: 10.1007/s00330-015-4133-1
  23. Silva M, Galeone C, Sverzellati N, Marchianò A, Calareso G, Sestini S, La Vecchia C, Sozzi G, Pelosi G, Pastorino U. Screening with Low Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer. J Thor Oncol Vol. 11 No. 2: 187-193. 
    doi:10.1016/j.jtho.2015.10.014.
  24. Milanese G, Silva M, Sverzellati N. Lung volume reduction of pulmonary emphysema: the radiologist task. Curr Opin Pulm Med. 2016 Mar;22(2):179-86. 
    doi: 10.1097/MCP.0000000000000252.
  25. Sverzellati N, Silva M, Calareso G, Galeone C, Marchianò A, Sestini S, Sozzi G, Pastorino U. Low-Dose Computed Tomography for Lung Cancer Screening: Comparison of Performance Between Annual and Biennial Screen. Eur Radiol. 2016 Nov;26(11):3821-3829. Epub 2016 Feb 11. 
    doi: 10.1007/s00330-016-4228-3
  26. Ariani A, Aiello M, Silva M, Alfieri V, Bonati E, Lumetti F, Delsante G, Sverzellati N, Chetta A. Quantitative CT Indexes Are Significantly Related To Exercise Oxygen Desaturation in Interstitial Lung Disease Related to Systemic Sclerosis. Clin Respir J. 2016 Feb 22. 
    doi: 10.1111/crj.12451
  27. Pastorino U, Boffi R, Marchianò A, Sestini S, Munarini E, Calareso G, Boeri M, Pelosi G, Sozzi G, Silva M, Sverzellati N, Galeone C, La Vecchia C, Ghirardi A, Corrao G. Stopping smoking reduces mortality in low-dose computed tomography (LDCT) screening volunteers. J Thorac Oncol. 2016 May;11(5):693-9. 
    doi: 10.1016/j.jtho.2016.02.011
  28. Milanese G, Capretti G, Sverzellati N, Silva M. Lung cancer screening: are we ready now? 
    Shortness of Breath Vol. 5 (No. 1) 2016 January-March. 
    doi: 10.11138/sob/2016.5.1.020 Not indexed in PubMed
  29. Sestini S, Boeri M, Marchianò A, Silva M, Calareso G, Galeone C, Sozzi G, Pastorino U. Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test. Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 1):42-50. 
    doi: 10.19191/EP16.1S1.P042.029
  30. Manna C, Silva M, Gazzani SE, Cobelli R. An uncommon cause of ascites: uroperitoneum from iatrogenic bladder fistula detected by CT urography. BJR Case Rep 2016; 2: 20150391. 
    doi: 10.1259/bjrcr.20150391. Not indexed in PubMed
  31. Infante M, Sestini S, Galeone C, Marchianò A, Lutman FR, Angeli E, Calareso G, Pelosi G, Sozzi G, Silva M, Sverzellati N, Cavuto S, La Vecchia C, Santoro A, Aloisio M, Pastorino U. Lung cancer screening with low dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials. Eur J Cancer Prev. 2017 Jul;26(4):324-329. 
    doi: 10.1097/CEJ.0000000000000264
  32. Bozzetti F, Paladini I, Rabaiotti E, Franceschini A, Alfieri V, Visca D, Chetta A, Crisafulli E, Silva M, Pastorino U, Sverzellati N. Are interstitial lung abnormalities associated with COPD? A nested case-control study. Int J Chron Obstruct Pulmon Dis. 2016 May 26;11:1087-96. 
    doi: 10.2147/COPD.S103256. 
  33. Silva M, Zambrini EI, Chiari G, Montermini I, Manna C, Poli T, Lanfranco D, Sesenna E, Thai E, Sverzellati N. Pre-surgical Assessment of Mandibular Bone Invasion from Oral Cancer: Comparison Between Different Imaging Techniques and Relevance of Radiologist Expertise. Radiol Med. 2016 Sep;121(9):704-10. 
    doi: 10.1007/s11547-016-0654-1
  34. Colombi D, Ehlers-Tenenbaum S, Palmowski K, Heussel CP, Sverzellati N, Silva M, Eichinger M, Kreuter M. Spontaneous Pneumomediastinum as a Potential Predictor of Mortality in Patients with Idiopathic Pulmonary Fibrosis. Respiration. 2016;92(1):25-33. 
    doi: 10.1159/000447430
  35. Crisafulli E, Alfieri V, Silva M, Aiello M, Tzani P, Milanese G, Bertorelli G, Sverzellati N, Chetta A. Relationships Between Emphysema and Airways Metrics at High-resolution Computed Tomography (HRCT) and Ventilatory Response to Exercise in Mild to Moderate COPD Patients. Respir Med. 2016 Aug;117:207-14. 
    doi: 10.1016/j.rmed.2016.06.016
  36. Pavarani A, Martini C, Gafà V, Bini P, Silva M, Ghetti C, Sverzellati N. Effect of iterative reconstruction on image quality of low-dose chest computed tomographic examinations. Acta Biomed. 2016 Sep 13;87(2):168-176. 
    PMID: 27648999
  37. Landini N, Milanese G, Zambrini E, Ariozzi I, Gnetti L, Carloni A, Nosenzo, Silva M, Sverzellati N. Computed Tomography-Histology Correlations of Unusual Lung Tumors. Pathologica 2016;108:110-119 
    PMID: 28195262
  38. Rasciti E, Sverzellati N, Silva M, Casadei A, Attinà D, Palazzini M, Galiè N, Zompatori M. Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension. Radiol Med. 2017 Apr;122(4):257-264. 
    doi: 10.1007/s11547-016-0714-6
  39. Ariani A, Silva M, Seletti V, Bravi E, Saracco M, Parisi S, De Gennaro F, Caramaschi P, Scirè C, Idolazzi L, Benini C, Bodini F, Lumetti F, Alfieri V, Bonati E, Lucchini G, Aiello M, Santilli D, Mozzani F, Imberti D, Michieletti E, Arrigoni E, Delsante G, Pellerito R, Fusaro E, Chetta AA, Sverzellati N. Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis. Rheumatology (Oxford). 2017 Feb 4. 
    doi: 10.1093/rheumatology/kew480.
  40. Silva M, Pastorino U, Sverzellati N. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials. Clin Radiol. 2017 May;72(5):389-400. 
    doi: 10.1016/j.crad.2016.12.021
  41. Marchianò A, Cosentino M, Di Tolla G, Greco FG, Silva M, Sverzellati N, Fabbri A, Tamborini E, Lo Russo G, Mariani L, Lalli L, Pastorino U. FNA and CNB in the diagnosis of pulmonary lesions: a single-center experience on 665 patients, comparison between two periods. Tumori. 2017 Apr 28:0. 
    doi: 10.5301/tj.5000633
  42. Manna C, Silva M, Poggesi S, Cobelli R, Rossi C, Sverzellati N. High-Pitch Dual-Source CT Angiography without ECG-gating for Imaging The Whole Aorta: Intra-individual Comparison with Standard Pitch Single-Source Technique. Diagn Interv Radiol. 2017 Jul-Aug;23(4):293-299. 
    doi: 10.5152/dir.2017.16617
  43. Milanese G, Sverzellati N, Pastorino U, Silva M. Adenocarcinoma in pure ground glass nodules: histological evidence of invasion and open debate on optimal management. J Thorac Dis 2017. 
    doi: 10.21037/jtd.2017.08.120 
  44. Pellegrino B, Facchinetti F, Bordi P, Silva M, Gnetti L, Tiseo M. Lung toxicity in non-small cell lung cancer patients exposed to ALK inhibitors: report of a peculiar case and systematic review of the literature. Clin Lung Cancer. 2018 Mar;19(2):e151-e161. 
    doi: 10.1016/j.cllc.2017.10.008
  45. Silva M, Milanese G, Seletti V, Ariani A, Sverzellati N. Pulmonary Quantitative CT Imaging in Focal and Diffuse Disease: Facing Clinical and Research Application. Br J Radiol. 2018 Feb;91(1083):20170644. doi: 10.1259/bjr.20170644
  46. Silva M, Sverzellati N, Colombi D, Milanese G, La Vecchia C, Galeone C, Marchianò A, Pastorino U. Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality. BMC Pulm Med. 2017 Nov 25;17(1):155. 
    doi: 10.1186/s12890-017-0506-3 
  47. Sverzellati N, Odone A, Silva M, Polverosi R, Florio C, Cortese G, Cardinale L, Addonisio G, Zompatori M, Dalpiaz G, Piciucchi S, Larici AR et al. Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist. Radiol Med. 2018 Apr;123(4):245-253. 
    doi: 10.1007/s11547-017-0835-6 
  48. Charbonnier JP, Chung K, Scholten ET, van Rikxoort EM, Jacobs C, Sverzellati N, Silva M, Pastorino U, van Ginneken B, Ciompi F. Automatic Vessel and Solid Core Segmentation in Pulmonary Subsolid Nodules. Sci Rep. 2018 Jan 12;8(1):646. 
    doi: 10.1038/s41598-017-19101-3
  49. Silva M, Schaefer-Prokop CM, Jacobs C, Capretti G, Ciompi F, van Ginneken B, Pastorino U, Sverzellati N. Detection of Subsolid Nodules in Lung Cancer Screening: Complementary Sensitivity of Visual Reading and Computer-Aided Diagnosis. Invest Radiol. 2018 Aug;53(8):441-449. 
    doi: 10.1097/RLI.0000000000000464
  50. Sverzellati N, Silva M. The matter of lung: quantification of vascular substance in asthma. Am J Respir Crit Care Med. 2018 Jun 8. doi: 10.1164/rccm.201804-0804ED.
  51. Silva M, Pastorino U, Sverzellati N. Prospective randomised controlled trial: fixed 1-year screening interval group versus a tailored intervals group. Thorax. 2018 eLetter: http://thorax.bmj.com/content/early/2018/03/29/thoraxjnl-2017-211107.responses#prospective-randomised-controlled-trial-fixed-1-year-screening-interval-group-versus-a-tailored-intervals-group
    Not indexed in PubMed.
  52. Silva M, Milanese G, Sverzellati N. Interstitial Lung Abnormalities: Definition of Prognostically Relevant Radiological Findings. Curr Opin Pulm Med. 2018 Sep;24(5):432-439. 
    doi: 10.1097/MCP.0000000000000497 
  53. Silva M, Prokop M, Jacobs C, Capretti G, Sverzellati N, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Galeone C, Marchianò A, Pastorino U. Long-term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment. J Thorac Oncol. 2018 Oct;13(10):1454-1463. 
    doi: 10.1016/j.jtho.2018.06.013
  54. Facchinetti F, Gnetti L, Balestra V, Silva M, Silini EM, Ventura L, Bordi P, Tiseo M. Sarcoid-like reaction mimicking disease progression in an ALK-positive NSCLC patient receiving lorlatinib. Invest New Drugs 2019. 37(2):360-363 
    doi: 10.1007/s10637-018-0652-3
  55. Walsh SLF, Calandriello L, Silva M, Sverzellati N. A Deep Learning Algorithm for Classifying Fibrotic Lung Disease on High-Resolution Computed Tomography. Lancet Respir Med. 2018 Nov;6(11):837-845. 
    doi: 10.1016/S2213-2600(18)30286-8
  56. Nair A, Bartlett EC, Walsh SLF, Wells AU, Navani N, Hardavella G, Bhalla S, Calandriello L, Devaraj A, Goo JM, Klein JS, MacMahon H, Schaefer-Prokop C, Seo JB, Sverzellati N, Desai SR; Lung Nodule Evaluation Group (Collaborators included Silva M). Variable radiologic lung nodule evaluation leads to divergent management recommendations. European Respiratory Journal 2018. 52(6):1-12  
    doi: 10.1183/13993003.01359-2018
  57. Milanese G, Silva M, Bruno L, Goldoni M, Benedetti G, Rossi E, Ferrari C, La Grutta L, Maffei E, Toia P, Bonadonna RC, Sverzellati N, Cademartiri F. Quantification of Epicardial Fat with cardiac CT and Association with Cardiovascular Risk Factors in Symptomatic Patients: from the ALTER-BIO (Alternative Cardiovascular Bio-Imaging Markers) Registry. Diagn Interv Radiol 2019; 25: 35-41. 
    doi: 10.5152/dir.2018.18037
  58. Papapietro VR, Milanese G, Borghesi A, Sverzellati N, Silva M. Look Around Your Target: a New Approach to Early Diagnosis of Lung Cancer. Ann Transl Med 2018;6(Suppl 1):S77. 
    doi: 10.21037/atm.2018.10.56
  59. Borghesi A, Michelini S, Nocivelli G, Silva M, Scrimieri A, Maroldi R, Farina D. Solid indeterminate pulmonary nodules ≤ 250 mm³: application of the updated Fleischner Society guidelines in clinical practice. Radiology Research and Practice 2019, Article ID 7218258 
    doi: 10.1155/2019/7218258
  60. Ariani A, Silva M, Bravi E, Parisi S, Saracco M, De Gennaro F, Caimmi C, Girelli F, De Santis M, Volpe A, Lumetti F, Hax V, Bredemeier M, Alfieri V, Santilli D, Bodini FC, Mozzani F, Lucchini G, Seletti V, Bacchini E, Arrigoni E, Chakr R, Giuggioli D, Idolazzi L, Bertorelli G, Imberti D, Michieletti E, Paolazzi G, Fusaro E, Chetta A, Scirè CA, Sverzellati N. Overall mortality in Combined Pulmonary Fibrosis and Emphysema related to Systemic Sclerosis. RMD Open 2019;5:e000820. 
    doi: 10.1136/rmdopen-2018-000820
  61. Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, A Marchianò. Prolonged Lung Cancer Screening Reduced 10-year Mortality in the MILD Trial: New Confirmation of Lung Cancer Screening Efficacy. Annals of Oncology (Published: 01 April 2019) 
    doi: 10.1093/annonc/mdz117 
  62. Ledda RE, Milanese G, Gnetti L, Borghesi A, Sverzellati N, Silva M. Spread through air spaces in lung adenocarcinoma: is radiology reliable yet? J Thorac Dis. 2019 Mar;11(Suppl 3):S256-S261. 
    doi: 10.21037/jtd.2019.01.96
  63. Milanese G, Silva M, Frauenfelder T, Eberhard M, Sabia F, Martini C, Marchianò A, Prokop M, Sverzellati N, Pastorino U. Comparison of Ultra-low Dose Chest CT Scanning Protocols for the Detection of Pulmonary Nodules: a Phantom Study. Tumori. 2019 May 1:300891619847271. 
    doi: 10.1177/0300891619847271
  64. Pastorino U, Sverzellati N, Sestini S, Silva M, Sabia F, Boeri M, Cantarutti A, Sozzi G, Corrao G, Marchianò A. Ten-year Results of the MILD Trial Demonstrate the Safety and Efficacy of Biennial Lung Cancer Screening. Eur J Cancer. 2019 Sep;118:142-148. 
    doi: 10.1016/j.ejca.2019.06.009
  65. Ravanelli M, Agazzi GM, Milanese G, Roca E, Silva M, Tiseo M, Rondi P, Baggi A, Ganeshan B, Muri M, Panni S, Botti C, Sverzellati N, Maroldi R, Berruti A, Farina D. Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: a multicentre retrospective study. Eur J Radiol. 2019 Sep;118:251-256. 
    doi: 10.1016/j.ejrad.2019.07.019
  66. Silva M, Milanese G, Pastorino U, Sverzellati N. Lung cancer screening: tell me more about post-test risk. J Thorac Dis 2019;11(9):3681-3688. 
    doi: 10.21037/jtd.2019.09.28
  67. Heidinger BH, Silva M, De Margerie-Mellon C, VanderLaan P, Bankier AA. The Natural Course of Incidentally Detected, Small, Subsolid Lung Nodules – Is Follow-Up Needed Beyond Current Guideline Recommendations? Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S412-S417. 
    doi: 10.21037/tlcr.2019.11.05
  68. Silva M, Milanese G, Cobelli R, Manna C, Rasciti E, Poggesi S, Sverzellati N. CT Angiography for Pulmonary Embolism in the Emergency Department: Optimized Protocol by 20 ml of High-Concentration Contrast Medium. La radiologia medica, 125(2), 137-144. 
    doi: 10.1007/s11547-019-01098-6
  69. Guisado-Vasco P, Silva M, Duarte MA, Sambataro G, Bertolazzi C, Pavone M, Martín-Garrido I, Martín-Segarra O, Luque-Pinilla JM, Santilli D, Sambataro D, Torrisi SE, Vancheri A, Gutiérrez-México M, Mejia M, Palmucci S, Mozzani F, Rojas-Serrano J, Vancheri C, Sverzellati N Ariani A. Quantitative assessment of interstitial lung disease in Sjögren’s syndrome. Plos ONE Volume 14, Issue 11, 2019, Article number e0224772. 
    doi: 10.1371/journal.pone.0224772
  70. Sverzellati N, Silva M, Seletti V, Galeone C, Palmucci S, Piciucchi S, Vancheri C, Poletti V, Tomassetti S, Karwoski R, Bartholmai BJ. Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity. Eur Radiol. 2020. Epub 2020 Jan 31. 
    doi: 10.1007/s00330-019-06619-5
  71. Kauczor HU, Baird AM, Blum TG, Bonomo L, Bostantzoglou C, Burghuber O, Čepická B, Comanescu A, Couraud S, Devaraj A, Jespersen V, Morozov S, Agmon IN, Peled N, Powell P, Prosch H, Ravara S, Rawlinson J, Revel MP, Silva M, Snoeckx A, van Ginneken B, van Meerbeeck JP, Vardavas C, von Stackelberg O, Gaga M, on behalf of the European Society of Radiology (ESR) and the European Respiratory Society (ERS). ESR-ERS joint position paper on Lung Cancer Screening. Eur Respir J. 2020 Feb;55(2). Print 2020 Feb. PubMed PMID: 32051182.
    doi: 10.1183/13993003.00506-2019
  72. Kauczor HU, Baird AM, Blum TG, Bonomo L, Bostantzoglou C, Burghuber O, Čepická B, Comanescu A, Couraud S, Devaraj A, Jespersen V, Morozov S, Agmon IN, Peled N, Powell P, Prosch H, Ravara S, Rawlinson J, Revel MP, Silva M, Snoeckx A, van Ginneken B, van Meerbeeck JP, Vardavas C, von Stackelberg O, Gaga M, on behalf of the European Society of Radiology (ESR) and the European Respiratory Society (ERS). ESR-ERS joint position paper on Lung Cancer Screening. Eur Radiol. 2020 Feb 12; . [Epub ahead of print] PubMed PMID: 32052170.
    doi: 10.1007/s00330-020-06727-7
  73. Sverzellati N, Milanese G, Milone F, Balbi M, Ledda RE, Silva M. Integrated Radiologic Algorithm for COVID-19 Pandemic. J Thorac Imaging. 2020 Jul;35(4):228-233. 
    doi: 10.1097/RTI.0000000000000516.
  74. Milanese G, Silva M, Ledda R, Goldoni M, Nayak SM, Bruno L, Rossi E, Maffei E, Cademartiri F, Sverzellati N. Validity of Epicardial Fat Volume as Biomarker of Coronary Artery Disease in Symptomatic Individuals: Results from the ALTER-BIO Registry. International Journal of Cardiology. Available online 13 April 2020. 
    doi: 10.1016/j.ijcard.2020.04.031
  75. Colombi D, Bodini FC, Petrini M, Maffi G, Morelli N, Milanese G, Silva M, Sverzellati N, Michieletti E. Visual and Software-based Quantification of Well Aerated Lung Obtained by Chest CT for Predictors in COVID-19 Interstitial Pneumonia. Radiology. 2020 Apr 17:201433. 
    doi: 10.1148/radiol.2020201433
  76. Revel MP, Parkar A, Prosch H, Silva M, Sverzellati N, Gleeso F, Brady AP; European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). COVID-19 patients and the Radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur Radiol. 2020 Sep;30(9):4903-4909.
    doi: 10.1007/s00330-020-06865-y
  77. Mazzaschi G, Milanese G, Pagano P, Madeddu D, Falco A, Trentini F, lorusso B, Gnetti L, Lagrasta C, Minari R, Ampollini L, Silva M, Sverzellati M, Tiseo M, Roti G. 
    Integrated CT Imaging and Tissue Immune Features Disclose a Radio-Immune Signature with High Prognostic Impact on Surgically Resected NSCLC. Lung Cancer. 2020 Jun;144:30-39. 
    doi: 10.1016/j.lungcan.2020.04.006
  78. Mazzaschi G, Milanese G, Pagano P, Madeddu D, Gnetti L, Trentini F, Falco A, Frati C, Lorusso B, Lagrasta C, Minari R, Ampollini L, Silva M, Sverzellati N, Quaini F, Roti G, Tiseo M. Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. Data in Brief Volume 31, August 2020, 105781
    doi: 10.1016/j.dib.2020.105781
  79. Scarlattei M, Baldari G, Silva M, Bola S, Sammartano A, Migliari S, Graziani T, Cidda C, Sverzellati N, Ruffini L. Unknown SARS-CoV-2 pneumonia detected by PET/CT in cancer patients. Tumori Journal publishd online 22 June 2020
    doi: 10.1177/0300891620935983
  80. Ruscitti F, Ravanetti F, Bertani V, Ragionieri L, Mecozzi L, Sverzellati N, Silva M, Ruffini L, Menozzi V, Civelli M, Villetti G, Stellari FF. Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography. Front Pharmacol. 2020 Jul 21;11:1117. 
    doi: 10.3389/fphar.2020.01117
  81. Colombi D, Villani GD, Maffi G, Risoli C, Bodini FC, Petrini M, Morelli N, Anselmi P, Milanese G, Silva M, Sverzellati N, Michieletti E. Qualitative and quantitative chest CT parameters as predictors of specific mortality in COVID-19 patients. Emerg Radiol. 2020 Dec;27(6):701-710. 
    doi: 10.1007/s10140-020-01867-1
  82. Silva M, Milanese G, Kauczor HU, Revel MP, Sverzellati N. Milestones towards lung cancer screening implementation. Clin Radiol. 2020 Aug 27:S0009-9260(20)30316-0. 
    doi: 10.1016/j.crad.2020.07.028
  83. Colombi D, Petrini M, Maffi G, Villani GD, Bodini FC, Morelli N, Milanese G, Silva M, Sverzellati N, Michieletti E. Comparison of admission chest computed tomography and lung ultrasound performance for diagnosis of COVID-19 pneumonia in populations with different disease prevalence. Eur J Radiol Epub 2020 Oct 8.
    doi: 10.1016/j.ejrad.2020.109344
  84. Balbi M, Ristani A, Milanese G, Silva M, Ledda RE, Milone F, Sartorio C, Tringali G, Sverzellati N. The role of the radiologist in diagnosing the covid-19 infection. Parma experiences. Acta Bio-Medica De L'ateneo Parmense - ISSN:0392-4203 vol. 91 (2)
    doi: 10.23750/abm.v91i2.9564
  85. Silva M, Maddalo M, Leoni E, Giuliotti S, Milanese G, Ghetti C, Biasini E, Missale G, Sverzellati N. Integrated prognostication of intrahepatic cholangiocarcinoma by contrast enhanced computed tomography: the adjunct yield of radiomics. Abdom Radiol (NY). 2021 Oct;46(10):4689-4700. Epub 2021 Jun 24.
    doi: 10.1007/s00261-021-03183-9
  86. Ugolotti MC, Pedrazzini M,  Silini EM, Missale G, Silva M, Franzini C, Palmieri G, Costi R, Montali F, Gnappi E, Terroni L, Colizzi E, Meschi M, Facchinetti F. Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient. Journal of Medical Virology 93(4), pp. 1940-1942
    doi: 10.1002/jmv.26803
  87. Silva M, Milanese G, Sestini S, Sabia F, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop CM, Marchianò A, Sverzellati N, Pastorino U. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval. European Radiology 31(4), pp. 1956-1968.
    doi: 10.1007/s00330-020-07275-w
  88. Balbi M, Caroli A, Corsi A, Milanese G, Surace A, Di Marco F, Novelli L, Silva M, Lorini F, Cosentini R, Sverzellati N, Bonaffini PA, Sironi S. Chest X-ray for predicting mortality and the need for ventilatory support in COVID-19 patients presenting to the emergency department. European Radiology 31(4), pp. 1999-2012
    doi: 10.1007/s00330-020-07270-1
  89. Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Interstitial lung disease in Sjögren’s syndrome: a clinical review. Clinical and Experimental Rheumatology 38(4), pp. S291-S300
    PMID: 33095142
  90. Carnevale A, Silva M, Maietti E, Milanese G, Saracco M, Parisi S, Bravi E, De Gennaro F, Arrigoni E, Bodini FC, Fusaro E, Scirè CA, Sverzellati N, Ariani A. Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests. Clinical Rheumatology 40(1), pp. 213-219.
    doi: 10.1007/s10067-020-05375-y
  91. Silva M, Ledda RE, Schiebler M, Balbi M, Milone F, Sverzellati N. Frequency of Typical and Ancillary Chest CT Findings in COVID-19 Infection. British Journal of Radiology 94(1118),20200716. 
    doi: 10.1259/bjr.20200716
  92. Bartlett E, Silva M, Callister M, Devaraj A. False negative results in lung cancer screening - Evidence and Controversies. Journal of Thoracic Oncology 16(6), pp. 912-921. 
    doi: 10.1016/j.jtho.2021.01.1607
  93. Sverzellati N, Ryerson C, Milanese G, Renzoni E, Volpi A, Spagnolo P, Bonella F, Comelli I, Manna C, Ciuni A, Sartorio C, Tringali G, Silva M, Michieletti E, Colombi D, Wells A. Chest radiography or computed tomography for suspected COVID-19 pneumonia? A comparative study in a simulated triage setting. European Respiratory Journal 58(3),2004188. 
    doi: 10.1183/13993003.04188-2020
  94. Schreuder A, Jacobs C, Lessmann N, Broeders MJ, Silva M, Išgum I, de Jong PA, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B. Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening. European Respiratory Journal 58(3),2003386. 
    doi: 10.1183/13993003.03386-2020
  95. Caminiti C, Maglietta G, Meschi T, Ticinesi A, Silva M, Sverzellati N. Effects of the Covid-19 epidemic on hospital admissions for Non-Communicable Diseases in a large Italian University-Hospital: a descriptive case-series study. Journal of Clinical Medicine 10(4),880, pp. 1-9
    doi: 10.3390/jcm10040880
  96. Avila R, Fain SB, Hatt C, Armato S, Mulshine JL, Gierada D, Silva M, Lynch DA, Hoffman EA, Ranallo F, Mayo JR, Yankelevitz D,  San Jose Estepar R, Subramaniam R, Henschke C, Guimaraes A, Sullivan D.
    QIBA Guidance: Computed Tomography Imaging for COVID-19 Quantitative Imaging Applications. Clinical Imaging 77, pp. 151-157.
    doi: 10.1016/j.clinimag.2021.02.017
  97. Ariani, Sverzellati N, Milanese G, Becciolini A, Silva M. Using quantitative computed tomography to predict mortality in patients with interstitial lung disease related to systemic sclerosis: implications for personalized medicine. Expert Review of Precision Medicine and Drug Development 6(1), pp. 31-40
    doi: 10.1080/23808993.2021.1858053
  98. Tringali G, Milanese G, Ledda RE, Pastorino U, Sverzellati N, Silva M. Lung Cancer Screening: evidence, harms and opportunities for implementation. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren 193(10), pp. 1153-1161.
    doi: 10.1055/a-1382-8648.
  99. Ma Q, Chen Y, Xiao F, Hao Y, Song Z, Zhang J, Okuda K, Um SW, Silva M, Shimada Y, Si C, Liang C. A Signature of Estimate-Stromal-Immune Score-Based Genes Associated with The Prognosis of Lung Adenocarcinoma. Translational Lung Cancer Research 10(3), pp. 1484-1500.
     doi: 10.21037/tlcr-21-223 
  100. Ventura L, Gnetti L, Rossi M, Tiseo M, Silini EM, Sverzellati N, Silva M, Milanese G, Minari R, Cattadori S, Bocchialini G, Ampollini L, Carbognani P, Mozzoni P. The role of miRNA-221 and miRNA-126 in patients with Benign Metastasizing Leiomyoma of the lung: an overview with new interesting scenarios. Molecular Biology Reports 48(4), pp. 3485-3494.
    doi: 10.1007/s11033-021-06322-z
  101. Ledda RE, Milanese G, Cademartiri F, Maffei E, Benedetti G, Goldoni M, Silva M, Sverzellati N. Association of hepatic steatosis with epicardial fat volume and coronary artery disease in symptomatic patients. Radiologia Medica 126(5), pp. 652-660 
    doi: 10.1007/s11547-020-01321-9
  102. Snoeckx A, Franck C, Silva M, Revel MP. Radiologist’s role in lung cancer screening. The radiologist’s role in lung cancer screening. Translational Lung Cancer Research 10(5), pp. 2356-2367.
    doi: 10.21037/tlcr-20-924
  103. Silva M, Milanese G, Ledda RE, Pastorino U, Sverzellati N. Screen-detected solid nodules: from nodule management to structured reporting. Transl Lung Cancer Res. 2021 May;10(5):2335-2346.
    doi: 10.21037/tlcr-20-296
  104. Ventura L, Carbognani P, Gnetti L, Rossi M, Tiseo M, Silini EM, Sverzellati N, Silva M, Succi M, Braggio C, Cattadori S, Bocchialini G, Balestra V, Rusca M, Ampollini L. Multiple primary malignancies involving lung cancer: a single-center experience. Tumori 107(3), pp. 196-203
    doi: 10.1177/0300891620933678
  105. Casartelli C, Perrone F, Balbi M, Alfieri V, Milanese G, Buti S, Silva M, Sverzellati N, Bersanelli M. Review on radiological evolution of COVID-19 pneumonia using computed tomography. World J Radiol 2021 September 28; 13(9): 294-306
    doi: 10.4329/wjr.v13.i9.294
  106. Colombi D, Bodini FC, Morelli N, Silva M, Milanese G, Cavanna L, Michieletti E. COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients. Journal of Infection and Chemotherapy 27(1), pp. 99-102
    doi: 10.1016/j.jiac.2020.09.008
  107. Sartorio C, Milanese G, Ledda RE, Tringali G, Balbi M, Milone F, Sverzellati N, Silva M. Diameter versus volumetry: A narrative review on current recommendations to measure and monitor screening detected lung nodules. Shanghai Chest 5(October),39
    doi: 10.21037/shc-21-5
  108. Buti S, Perrone F, Zielli T, Mazzaschi G, Casartelli C, Leonetti A, Milanese G, Silva M, Ledda RE, Musolino A, Pucci F, Bersanelli M, Tiseo M. Clinical Impact Of COVID-19 Outbreak On Cancer Patients: A Retrospective Study. Clinical Medicine Insights: Oncology 2021 Volume 15: 1–8
    doi: 10.1177/11795549211043427
  109. Jacobs C, Setio AAA, Scholten ET, Gerke PK, Bhattacharya H, Mohamed Hoesein F, Brink M, Ranschaert E, de Jong P, Silva M, Geurts B, Chung K, Schalekamp S, Meersschaert J, Devaraj A, Pinsky P, Lam S, van Ginneken B, Farahani K. Lung Cancer Detection in Screening CT Scans: Results from a Public Machine Learning Competition and an Observer Study. Radiology: Artificial Intelligence 3(6),e210027.
    doi: 10.1148/ryai.2021210027
  110. Martini K, Larici AR, Revel MP, Ghaye B, Sverzellati N, Parkar AP, Snoeckx A, Screaton N, Biederer J, Prosch H, Silva M, Gleeson F, Brady A, Frauenfelder T. COVID-19 pneumonia imaging follow-up: when and how? A proposition from ESTI and ESR. European Radiology 32(4), pp. 2639-2649
    doi: 10.1007/s00330-021-08317-7
  111. Lancaster HL, Zheng S, Aleshina OO, Yu D, Chernina VY, Heuvelmans MA, Dorrius MD, Gratama JW, Morozov SP, Gombolevsky VA, Silva M, Yi J, Oudkerk M. Outstanding negative prediction performance of solid pulmonary nodule volume AI for ultra-LDCT baseline lung cancer screening risk stratification. Lung Cancer 2022 Jan 6;165:133-140
    doi: 10.1016/j.lungcan.2022.01.002
  112. Silva M, Milanese G, Ledda RE, Nayak SM, Pastorino U, Sverzellati N. European lung cancer screening: valuable trial evidence for optimal practice implementation. British Journal of Radiology 95(1133),20200260
    doi: 10.1259/bjr.20200260
  113. Trentini F, Mazzaschi G, Milanese G, Madeddu D, Gnetti L, Frati C, Lorusso B, Lagrasta C, Minari R, Ampollini L, Ledda RE, Pavone C, Silva M, Sverzellati N, Quaini F, Roti G, Tiseo M. A Validation of a Radiomic Approach to Decipher NSCLC Immune Microenvironment in Surgically Resected Patients. Tumori 108(1), pp. 86-92.
    doi: 10.1177/03008916211000808
  114. Ledda RE, Milanese G, Milone F, Balbi M, Silva M, Sverzellati N. Interstitial lung abnormalities: new insights between theory and clinical practice. Insights into Imaging 13(1),6.
    doi: 10.1186/s13244-021-01141-z
  115. Ledda RE*, Silva M*, McMichael N, Sartorio C, Branchi C, Milanese G, Nayak SM, Sverzellati N. The diagnostic value of grey-scale inversion technique in chest radiography. Radiologia Medica 127(3), pp. 294-304. 
    doi: 10.1007/s11547-022-01453-0
  116. Pastorino U, Boeri M, Sestini S, Sabia F, Milanese G, Silva M, Suatoni P, Verri C, Cantarutti A, Sverzellati N, Corrao G, Marchianò A, Sozzi G. 
    Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial. Ann Oncol. 2022 Jan 25;S0923-7534(22)00017-5
    doi: 10.1016/j.annonc.2022.01.008
  117. Huang LT, Cui M, Silva M, Wang JH, Wang YB. Expression Profiles of tRNA-Derived Fragments and Their Potential Roles in Lung Adenocarcinoma. Ann Transl Med. 2022 Feb;10(4):196. 
    doi: 10.21037/atm-22-119
  118. Schreuder A, Jacobs C, Lessmann N, Broeders MJM, Silva M, Išgum I, de Jong PA, van den Heuvel MM, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B. Scan-based competing death risk model for reevaluating lung cancer computed tomography screening eligibility. European Respiratory Journal 59(5),2101613
    doi: 10.1183/13993003.01613-2021
  119. Silva M, Picozzi G, Sverzellati N, Anglesio S, Bartolucci M, Cavigli E, Deliperi A, Falchini M, Falaschi F, Ghio D, Gollini P, Larici AR, Marchianò AV, Palmucci S, Preda L,  Romei C, Tessa C, Rampinelli C, Mascalchi M. Low-dose CT for Lung Cancer Screening: Italian Position Paper. Radiol Med. 2022 Mar 20;1-17. 
    doi: 10.1007/s11547-022-01471-y
  120. Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper  WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-resolution Computed Tomography. American journal of respiratory and critical care medicine 206(7), pp. 883-891
    doi: 10.1164/rccm.202112-2684OC
  121. Humphries S, ; Mackintosh J, Jo H, Walsh S, Calandriello L, Glaspole I, Corte TJ, Silva M, Chapman S, Ellis S, Goh N, Grainge C, Hopkins P, Keir G, Moodley Y, Reynolds P, Walters H, Lynch D. Quantitative CT Predicts Patient Outcomes in IPF: Analysis from the Australian IPF Registry. Respirology 27(12), pp. 1045-1053
    doi: 10.1111/resp.14333
  122. Qian L, Zhou Y, Zeng W, Chen X, Ding Z, Shen Y, Qian Y, Tosi D, Silva M, Han Y, Fu X.  A random forest algorithm predicting model combining intraoperative frozen section analysis and clinical features guides surgical strategy for peripheral solitary pulmonary nodules. Transl Lung Cancer Res. 2022 Jun;11(6):1132-1144
    doi: 10.21037/tlcr-22-395
  123. Mambrini M, Mecozzi L, Ferrini E, Leo L, Bernardi D, Grandi A, Sverzellati N, Ruffini L, Silva M, Stellari FF. The importance of routine quality control for reproducible pulmonary measurements by in vivo micro-CT. Sci Rep. 2022 Jun 11;12(1):9695
    doi: 10.1038/s41598-022-13477-7
  124. Sambataro D, Colaci M, Battisti S, Orlandi M, Cavagna L, Fazio G, Sverzellati N, Silva M, Malatino L, Ariani A. Feasibility, face and content validity of Quantitative Computed Tomography in Interstitial Lung Disease related to Connective Tissue Diseases. Journal of Basic and Clinical Physiology and Pharmacology 33(4), pp. 493-497
    doi: 10.1515/jbcpp-2021-0110
  125. Mulshine JL, Aldigé CR, Ambrose LF, Armato SG 3rd, Avila RS, Cham M, San Jose Estepar R, Fain SB, Gazourian L, Gierada DS, Hatt C, Henschke CI, Hoyos J, Lynch DA, McGlothlin AK, Oudkerk M, Pasquinelli M, Pinsky P, Pyenson B, Rizzo AA, Ross SM, Schmitz KH, Silva M, Okwuosa T, Washko G, Wisnivesky J, Yankelevitz DF, Zulueta JJ. Emphysema Detection in the Course of Lung Cancer Screening: Optimizing a Rare Opportunity to Impact Population Health. Ann Am Thorac Soc.
    doi: 10.1513/AnnalsATS.202207-631PS
  126. Milanese G, Mazzaschi G, Ledda RE, Balbi M, Lamorte S, Caminiti C, Colombi D, Tiseo M, Silva M, Sverzellati N. The radiological appearances of lung cancer treated with immunotherapy. Br J Radiol. 20210270. 
    doi: 10.1259/bjr.20210270
  127. Nair A, Dyer DS, Heuvelmans MA, Mashar M, Silva M, Hammer MM. Contextualizing the Role of Volumetric Analysis in Pulmonary Nodule Assessment: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2023 Mar;220(3):314-329.
    doi: 10.2214/AJR.22.27830
  128. Balbi M, Sabia F, Ledda RE, Milanese G, Ruggirello M, Silva M, Marchianò AV, Sverzellati N, Pastorino U. Automated coronary artery calcium and quantitative emphysema in lung cancer screening: association with mortality, lung cancer incidence, and airflow obstruction. J Thorac Imaging. 2023 Jan 20. Online ahead of print
    doi: 10.1097/RTI.0000000000000698
  129. Voigt W, Prosch H, Silva M. Clinical Scores, Biomarkers and IT Tools in Lung Cancer Screening-Can an Integrated Approach Overcome Current Challenges? Cancers (Basel). 2023 Feb 14;15(4):1218. 
    doi: 10.3390/cancers15041218
  130. Hunter B, Argyros C, Inglese M, Linton-Reid K, Pulzato I, Nicholson A, Kemp SV, Shah P, Molyneaux PL, McNamara C, Burn T, Guilhem E, Mestas Nuñez M, Hine J, Choraria A, Jordan S, Padley S, Ridge C, Robinson G, Robbie H, Barnett J, Silva M, Desai S, Aboagye EO, Devaraj A. Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis. British Journal of Cancer, 2023
    doi: 10.1038/s41416-023-02480-y
  131. Colombi D, Petrini M, Morelli N, Silva M, Milanese G, Sverzellati N, Michieletti E. Are Interstitial Lung Abnormalities a Prognostic Factor of Worse Outcome in COVID-19 Pneumonia? J Thorac Imaging. 2023 Feb 27. Online ahead of print.
    doi: 10.1097/RTI.0000000000000704
  132. Milanese G, Ledda RE, Sabia F, Ruggirello M, Sestini S, Silva M, Sverzellati N, Marchianò AV, Pastorino U. Ultra-low dose computed tomography protocols using spectral shaping for lung cancer screening: Comparison with low-dose for volumetric LungRADS classification. Eur J Radiol. 2023 Feb 28;161:110760. Online ahead of print.
    doi: 10.1016/j.ejrad.2023.110760
  133. Ventura L, Gnetti L, Milanese G, Rossi M, Leo L, Cattadori S, Silva M, Leonetti A, Minari R, Musini L, Pensato N, Illica Magrini F, Bocchialini G, Silini EM, Tiseo M, Sverzellati N, Carbognani P. Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights.
    Arch Bronconeumol. 2023 Jul;59(7):418-426. 
    doi: 10.1016/j.arbres.2023.03.015
  134. Ghetti C, Ortenzia O, Bertolini M, Sceni G, Sverzellati N, Silva M, Maddalo M. Lung Dual Energy CT: impact of different technological solution on quantitative analysis. Eur J Radiol 2023 Jun;163:110812.
    doi: 10.1016/j.ejrad.2023.110812
  135. Girard  N, Ponce Aix  S, Cedres S, Berghmans  T, Burgers  S, Toffart  AC, Popat  S, Janssens  A, Gervais  R, Hochstenbag  M, Silva  M, Burger  IA, Prosch  H, Stahel  R, Xenophontos  E, Pretzenbaher  Y, Neven  A, Peters  S. Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial. ESMO Open 2023 Jun;8(3):101576. 
    doi: 10.1016/j.esmoop.2023.101576
  136. M García Henao JA, Depotter AGA, Brown DV, Bajercius H, Todorova P, Saint-james H, Pahuddemortanges A, Barroso MC, He G, Yang J, You C, Staib L, Gange C, Ledda RE, Caminiti C, Silva M, Cortopassi I, Oliva IB, Dela Cruz C, Hautz W, Bonel H, Sverzellati N, Duncan J, Reyes M, Pöllinger A. A Multiclass Radiomics Method-Based WHO Severity Scale for Improving COVID-19 Patient Assessment and Disease Characterization From CT Scans. Investigative radiology, 2023, 58(12), pp. 882–893.
    doi: 10.1097/RLI.0000000000001005
  137. Venkadesh KV, Aleef  TA, Scholten  ET, Saghir  Z, Silva  M, Sverzellati  N, Pastorino  U, van Ginneken  B, Prokop  M, Jacobs C. Prior CT Improves Deep Learning for Malignancy Risk Estimation of Screening-detected Pulmonary Nodules. Radiology 2023 Aug;308(2):e223308.
    doi: 10.1148/radiol.223308
  138. Colombi D, Petrini M, Risoli C, Mangia A, Milanese G, Silva M, Franco C, Sverzellati N, Michieletti E. Quantitative CT at Follow-Up of COVID-19 Pneumonia: Relationship with Pulmonary Function Tests. Diagnostics 2023, 13(21), 3328
    doi: 10.3390/diagnostics13213328
  139. Behr C, Koffijberg H, IJzerman M, Kauczor HU, Revel MP, Silva M, von Stackelberg O, van Til J, Vliegenthart R. Willingness to participate in combination screening for lung cancer, chronic obstructive pulmonary disease and cardiovascular disease in four European countries.
    Eur Radiol, Published Online December 7, 2023
    doi: 10.1007/s00330-023-10474-w
  140. Desai SR, Sivarasan N, Johannson KA, George PM, Culver DA, Devaraj A, Lynch DA, Milne D, Renzoni E, Nunes H, Sverzellati N, Spagnolo P, Baughman Rp, Yadav R, Piciucchi S, Walsh SLF, Kouranos V, Wells AU, and the Sarcoid Delphi Group* (*Silva M is part of the Sarcoid Delphi Group). High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study.
    Lancet Respir Med 2023, Published Online December 14, 2023
    doi: 10.1016/S2213-2600(23)00267-9

     

Submitted Articles

  1. Lung cancer: Aleshina OO, Lancaster HL, Zheng S, Chernina VY, Heuvelmans MA, Silva M, Dorrius MD, Morozov SP, Gombolevsky VA, Oudkerk M. Volumetry versus linear diameter lung nodule measurement; an ultra-low-dose CT Lung Cancer Screening Study.
  2. Respiratory research: Grandi A, Ferrini E, Ciccimarra R, Mambrini M, Mecozzi L, Leo L, Silva M, Sverzellati N, Donofrio G, Ruffini L, Villetti G, Stellari FF. Multimodality approach to characterizing the distinctive hallmarks of lung fibrosis: a mouse model with bleomycin and indocyanine green.
  3. Europan Journal of Radiology: Ledda RE, Schirò S, Leo L, Milanese G, Branchi C, Palo AC, Commisso C, Borgia E, Mura R, Zilioli C, Ghetti G, Silva M, Marrocchio C, Sverzellati N. Diagnostic performance of chest CT average intensity projection (AIP) reconstruction for the assessment of pleuro-parenchymal abnormalities.
  4. Journal of Thoracic Imaging: Balbi M. et al. Longitudinal changes of CT-radiomic and systemic inflammatory features predict survival in advanced NSCLC patients treated with immune checkpoint inhibitors.
  5. Medical Image Analysis: Yang J, Anderson Garcia Henao J, Dvornek N, He J, Bower DV, Depotter A, Bajercius H, Pahud de Mortanges A, You C, Gange C, Ledda RE, Silva M, Dela Cruz CS, Hautz W, Bonel HM, Reyes M, Staib LH, Poellinger A, Duncan JS. Prior Knowledge-Guided Vision-Transformer-Based Unsupervised Domain Adaptation for Intubation Prediction in Lung Disease at One Week
  6. Lancet Respiratory Medicine: Jiang B, Han D, van der Aalst CM, Lancaster HL, Vonder M, Gratama JWC, Silva M, Field JK, de Koning HJ, Heuvelmans MA, Oudkerk M. Lung cancer volume-doubling time by Computed Tomography: a systematic review and meta-analysis
  7. Radiology: Sverzellati N, Milanese G, Ryerson CJ, Hatabu H, Walsh SLF, Papapietro R, Gazzani SE, Bacchini E, Specchia F, Capretti G, Ledda RE, Milone F, Silva M, Iezzi E. Interstitial Lung Abnormalities In Unselected Abdominal And Thoraco-Abdominal Ct Scans: The “Prevalence” Study On 21,118 Patients

 

Congresses And CoursesAbstract Of Scientific Poster Presentation

1.     RSNA 2010 (Congress of the Radiological Society of North America) - Chicago, Illinois

De Filippo M, Silva M, Johnson KM, Bertone C, Zompatori M, Rossi C. Accuracy of Multiplanar Reformatted CT Imaging in the Quantification of Glenoid Bone Loss Following Shoulder Dislocation.

2.     ECR 2011 (Congress of the European Society of Radiology) - Vienna, Austria

Martini C, Maffei E, Sverzellati N, Silva M, Arcadi T, Seitun T, Clemente A, Lario C, Cademartiri F; Parma/IT. #3826 - C-1169 Coronary calcium score assessed on unenhanced low-dose chest CT: feasibility study. Type: Scientific Paper.

3.     ESTI meeting 2012 (Meeting of the European Society of Thoracic Imaging) - London, United Kingdom

Silva M, Colombi D, Buttarelli L, Ranalli A, Seletti V, Mereu M, Rossi C, Sverzellati N. Extension of Pulmonary Fibrosing Diseases: a Comparison of Quantification Scoring Systems.

4.     Quantitative CT Symposium at STR Meeting 2014, March 15 (Society of Thoracic Radiology) - San Antonio, Texas 

Silva M, Nemec S, Dufresne V, Molinari F, Bankier AA. Lobar Contribution to Lung Volume in Healthy Subjects: Quantitative Assessment by CT.

5.     ATS Meeting 2014, May 16-21 (Meeting of the American Thoracic Society) – San Diego, California

DuBrock HM, Bankier AA, Silva M, Litmanovich DE, Curry MP, Washko GR. Pulmonary vessel cross-sectional area before and after liver transplant.

6.     100th Meeting of the Radiological Society of North America (RSNA), November 30 – December 5, 2014 – Chicago, IL

Silva M, Nemec SF, Heidinger BH, Occhipinti M, Dufresne V, Molinari F, Bankier AA. Lung Volume and Heterogeneity: CT Quantification of Lobar Contribution.

7.     16th World Congress on Lung Cancer , September 6-9, 2015 (International Association for Surgery of Lung Cancer – IASLC) – Denver, Colorado

Silva M, Galeone C, Sverzellati N, Marchianò A, Calareso G, Sestini S, La Vecchia C, Sozzi G, Pelosi G, Pastorino U. Small Cell Lung Cancer in Lung Cancer Screening: Frequency and Outcome.

8.     European Respiratory Society (ERS) International Congress 2015, September 26-30 – Amsterdam, The Netherlands.

Alfieri V, Milanese G, Panagiota T, Aiello M, Silva M, Sverzellati N, Marangio E, Chetta A. COPD Phenotypes by High Resolution Computed Tomography (HRCT) and Ventilatory Response to Exercise

  1. ECR 2016, March 2-6 (European Congress of Radiology) - Vienna, Austria
    Milanese G, Silva M, Borghesi A, Bezzi M, Bonifazi M, Novali M, Sverzellati N. Treatment of emphysema: procedure planning and follow-up by HRCT
  2. Joint Meeting of European Society of Thoracic Imaging (ESTI) and European Society of Cardiovascular Radiology (ESCR) – Geneva 2018, Switzerland
    Casilli E, Silva M, Milanese G, Sverzellati N. Quantitative CT imaging of the lung: Current applications and future perspectives in diagnostics of nodule and diffuse lung disease
  3. European Congress of Rheumatology EULAR 2018 – Amsterdam, The Netherlands.
    Bertolazzi C, Silva M, Rojas-Serrano J, Carnevale A, Sverzellati N, Gutierrez M, Alfaro-Rodriguez A, Ariani A. Quantitative CT Indexes in the Evaluation of Interstitial Lung Disease Related to Rheumatoid Arthritis
  4. National Research Program 78 “Covid-19” 1st Programme Conference – April 28-29, 2021 – Online from Bern, Switzerland. 
    AI-multi-omics-based Prognostic Stratification of COVID-19 Patients in Acute and Chronic State.
    PIs: Pöllinger A, Reyes M, Duncan J, Sverzellati N.
    Project Partners: Cortopassi IO, Hautz W, Dela Cruz C, Caminiti C.
    Team Members: Garcia Henao JA, He G, Silva M, Staib L, You C, Yang J, Gange C, Bajercius H, Depotter A, Barroso C, Schröder E, Pahud de Mortanges A.
  5. European Society of Medical Oncology (ESMO) 2021 Conference, September 16-21 – Online
    Mazzaschi G, Scandino R, Milanese G, Pavone C, Balbi M, Moron Dalla Tor L, Silva M, Ledda RE, Minari R, Trentini F, Bordi P, Buti S, Leonetti A, Quaini F, Sverzellati N, Romanel A, Tiseo M. #3456 A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
  6. CHEST Congress 2022, June 27-29 Bologna (IT)
    Lancaster H, Zheng S, Aleshina O, Yu D, Chernina V, Heuvelmans M, De Bock G, Dorrius M, Gratama Jw, Morozov S, Gombolevskiy V, Silva M, Yi J, Oudkerk M.
    Inter-Reader Agreement When Using Artificial Intelligence For Classification Of Solid Pulmonary Nodules In Ultra-Low Dose CT Baseline Lung Cancer Screening
    DOI: https://doi.org/10.1016/j.chest.2022.04.099
  1. International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2023 (WCLC2023) – September 9-12, Singapore
    Vonder M, van der Aalst C, Hubert J, Moldovanu D, Schmitz A, Gratama JWC, Silva M, de Koning H, Oudkerk M.
    Dedicated Cardiovascular Screening in Lung Cancer Screening: Preliminary Results from the European 4-IN-THE-LUNG-RUN Trial

 Abstract Of Oral PresentationsYear 2011

ECR 2011, March 6-10 (European Congress of Radiology) - Vienna, Austria

  1. Sverzellati N, Randi G, Calabrò E, Silva M, Kunhigk JM, Marchianò A, Zompatori M, Pastorino U. Relationship between lung cancer and pulmonary emphysema.

Year 2014

Third Systemic Sclerosis World Congress, February 6-8, 2014

  1. Ariani A, Lumetti F, Santilli D, Mozzani F, Silva M, Delsante G, Sverzellati N. Systemic sclerosis interstitial lung disease evaluation: comparison between semiquantitative and quantitative CT assessment.

ECR 2014, March 6-10 (European Congress of Radiology) - Vienna, Austria

  1.  Silva M, Centra F, Colombi D, Rossi C, Sverzellati N, Bankier AA. Ground glass nodules: CT-epidemiological analysis of growth patterns.
  2. Silva M, Kienzl D, Mueller-Mang C, Jaskch P, Klepetko W, Bankier AA. Quantitative CT in the follow up of functionally stable lung transplant recipients.
  3. Silva M, Centra F, Colombi D, Ampollini L, Carbognani P, Rossi C, Sverzellati N. Ground glass nodules evolution according with an history of tumour.
  4. Colombi D, Diciotti S, Manna C, Montermini I, Fontana E, Rossi C, Silva M, Tiseo M, Sverzellati N. Three-dimensional analysis of advanced stage NSCLC: prognostic significance of volumetric measurements

STR Meeting 2014, March 16-18 (Society of Thoracic Radiology) - San Antonio, Texas

  1. Silva M, Centra F, Colombi D, Rossi C, Sverzellati N, Bankier AA. Ground glass nodules: CT-epidemiological analysis of growth patterns.
  2. Silva M, Kienzl D, Mueller-Mang C, Jaskch P, Klepetko W, Bankier AA. Quantitative CT in the follow up of functionally stable lung transplant recipients.

Congresso Nazionale SIRM 2014, May 22-25 (Societa Italiana di Radiologia Medica) - Firenze, Italy

  1. Silva M, Centra F, Colombi D, Rossi C, Sverzellati N, Bankier AA. Noduli subsolidi: analisi radiologico epidemiologica dei pattern di evoluzione.
  2. Silva M, Kienzl D, Mueller-Mang C, Jaskch P, Klepetko W, Bankier AA. Analisi quantitative della tomografia computerizzata nel follow up del trapianto polmonare bilaterale in pazienti clnicamente stabili.

100th Meeting of the Radiological Society of North America (RSNA), November 30 – December 5, 2014 – Chicago, IL

  1. Silva M, Kienzl D, Mueller-Mang C, Jaskch P, Klepetko W, Bankier AA. Longitudinal Assessment of Tissue Loss and Air Trapping in Functionally Stable Lung Transplant Recipients Using Quantitative CT measurements.

Year 2015

ECR 2015, March 4-8 (European Congress of Radiology) - Vienna, Austria

  1. Silva M, Sverzellati N, Colombi D, La Vecchia C, Galeone C, Marchiano A, Pastorino U. Pleural abnormalities in lung cancer screening trial: prevalence, features, and relation with cancer.

American Thoracic Society 2015 International Conference, May 15-20, 2015 – Denver, CO

  1. Colombi D, Sverzellati N, Silva M, Kauczor HU, Ehlers-Tenenbaum S, Baroke E, Herth FJ, Heussel CP, Eichinger M, Kreuter M. Spontaneous Pneumomediastinum Is A Predictor Of Mortality In Patients With Idiopathic Pulmonary Fibrosis

Joint Meeting of European Society of Thoracic Imaging (ESTI) and Fleischner Society 2015, June 4-6 – Barcelona, Spain

  1. Silva M, Sverzellati N, Colombi D, La Vecchia C, Galeone C, Marchiano A, Pastorino U. Prevalence and features of pleural abnormalities in lung cancer screening trial: relation with asbestos exposure and risk of lung cancer.

Year 2016

ECR 2016, March 2-6 (European Congress of Radiology) - Vienna, Austria.

  1. Silva M, Sverzellati N, Galeone C, Calareso G, Marchianò A, Sestini S, Sozzi G, Pastorino U. Low­Dose Computed Tomography for Lung Cancer Screening: Comparison of Performance Between Annual and Biennial Screen.

Congresso Nazionale SIRM 2016, September 15-18 (Societa Italiana di Radiologia Medica) - Napoli, Italy

  1. Zambrini E, Silva M, Chiari G, Montermini I, Manna C, Sverzellati N. Valutazione pre-chirurgica dell’invasione mandibolare nelle neoplasie del cavo orale: confronto tra diverse metodiche di imaging e fra diversi livelli di esperienza specialistica
  2. Silva M, Sverzellati N, Marchianò A, Galeone C, Sestini S, Pastorino U. Screening del Tumore Polmonare con Tomografia Computerizzata a Bassa Dose: Confronto di Prestazioni tra Screening Annuale e Biennale

Year 2017

ECR 2017, March 1-5 (European Congress of Radiology) - Vienna, Austria.

  1. Silva M, Capretti G, Sverzellati N, Jacobs J, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Marchianò A, Pastorino U.  Subsolid and Part-Solid Nodules In Lung cancer Screening: Comparison Between Visual and Computer-Aided Detection.

4th World Congress of Thoracic Imaging (WCTI), June 18-21 – Boston (MA), USA

  1. Silva M, Capretti G, Sverzellati N, Jacobs J, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Prokop M, Marchianò A, Pastorino U.  Subsolid and Part-Solid Nodules In Lung cancer Screening: Comparison Between Visual and Computer-Aided Detection.

Year 2018

ECR 2018, February 28 - March 4 (European Congress of Radiology) - Vienna, Austria.

  1. Milanese G, Silva M, Bruno L, Goldoni M, Maffei E, Cademartiri F, Sverzellati N. Epicardial fat volume as a potential imaging biomarker for coronary artery disease in symptomatic patients.
  2. Milanese G, Silva M, Seletti V, Galeone C, Bartholmai BJ, Palmucci S, Piciucchi S, Karwoski RA, Sverzellati N. Follow-Up of Idiopathic Pulmonary Fibrosis: Computed Tomography vs Functional Metrics.
  3. Silva M, Jacobs C, Galeone C, Capretti G, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Prokop M, Marchianò A, Pastorino U, Sverzellati N. Active surveillance of subsoil nodules detected by screening: safe strategy to reduce overtreatment. 

Joint Meeting of European Society of Thoracic Imaging (ESTI) and European Society of Cardiovascular Radiology (ESCR), May 24-26 - Geneva, Switzerland.

  1. Silva M, Milanese G, Seletti V, Galeone C, Bartholmai BJ, Palmucci S, Piciucchi S, Karwoski RA, Sverzellati N. Information from Computed Tomography follow-up in Idiopathic Pulmonary Fibrosis: iPFBC Multicenter Pooled Comparison with clinical and functional metrics

European Society of Medical Oncology (ESMO) 2018 Conference, October 19-23 – Munich, Germany

  1. Cavalieri S, De Cecco L, Calareso G, Silva M, Gazzani SE, Bologna M, Nauta I, Wesseling F, Lopez Perez L, Shefi R, Tountopoulos V, Fico G, Scheckenbach K, Brakenhoff RH, Hoebers F, Canevari S, Poli T, Licitra L, Mainardi L, BD2Decide Consortium. Genomics features (GF) and integration with MRI radiomics features (RF) to develop a prognostic model in oral cavity squamous cell carcinoma (OSCC)

Year 2019

ECR 2019, February 28 - March 3 (European Congress of Radiology) - Vienna, Austria.

  1. Pastorino U, Silva M, Sabia F, Sestini S, Boeri M, Sozzi G, Sverzellati N, Marchianò A. Low-dose computed tomography (LDCT) screening reduces overall and lung cancer specific mortality beyond 5 years.
  2. Silva M, Sabia F, Milanese G, Sestini S, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop CM, Sverzellati N, Marchianò A, Pastorino U. Lung cancer risk after baseline round of screening: only 20% of NLST eligibles require annual round. [Selected for Clinical Trials in Radiology (CTiR) scientific session, discussant Prof. Kauczor H.U.; invited abstract for the press conference within the CTiR]
  3. Colombi D, Chiesa S, Bodini F, Morelli N, Silva M, Sverzellati N, Franco C, Michieletti E. Difference between measurement of T size at Computed Tomography and at resected specimen: is it relevant for NSCLC stage?
  4. Milanese G, Cobelli R, Manna C, Silva M, Rasciti E, Poggesi S, Sverzellati N. CT angiography for pulmonary embolism in the emergency department: diagnostic accuracy of 20ml high-concentration contrast medium.

Joint Meeting of European Society of Thoracic Imaging (ESTI) and Fleischner Society 2019, May 9-11 – Paris, France

  1. Silva M, Sabia F, Sestini S, Boeri M, Sozzi G, Marchianò A, Sverzellati N, Pastorino U. Low-dose computed tomography (LDCT) screening reduces lung cancer mortality beyond 5 years.
  2. Silva M, Milanese G, Sabia F, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop CM, Marchianò A, Sverzellati N, Pastorino U. Lung cancer risk after baseline round of screening: only 20% of NLST eligibles require annual round.
  3. Milanese G, Silva M, Frauenfelder T, Eberhard M, Sverzellati N, Pastorino U. Comparison of Ultra-Low Dose Chest CT Scanning Protocols for the Detection  Pulmonary Nodules According to LungRADS Categories: a Phantom Study. 

105th Meeting of the Radiological Society of North America (RSNA), December 1 – 6, 2019 – Chicago, IL

  1. Silva M, Milanese G, Sabia F, Jacobs C, van Ginneken B, Prokop M, Schaefer-Prokop C, Sestini S, Marchianò A, Sverzellati N, Pastorino U. Lung Cancer Screening in NLST Eligibles: Tailoring Annual Low-Dose Computed Tomography by Post-Test Risk Stratification

Year 2020

European Society of Medical Oncology (ESMO) 2020 Conference, December 9-12  – Online

  1. Menis J, Bironzo P, Radj G, Greillier L, Monnet I, Livi L, Young R, Decroisette C, Cloarec N, Robinet G, Schott R, Califano R, De Marinis F, Mauer M, Pochesci A, Silva M, Caramella C, Dingemans AM, Dive C, Besse B. Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab. (NCT02580994)
    url: https://doi.org/10.1016/j.annonc.2020.10.494

Year 2021

European Society of Medical Oncology (ESMO) 2021 Conference, September 16-21 – Online

  1. Girard N, Ponce Aix S, Cedres S, Berghmans T, Burgers S, Toffart AC, Popat S, Janssens A, Gervais R, Hochstenbag M, Silva M, Burger IA, Prosch H, Stahel R, Govaerts AS, Pochesci A, Neven A, Peters S. Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: Results from the EORTC-ETOP NIVOTHYM phase II trial. (NCT03134118)
    url: https://doi.org/10.1016/j.annonc.2021.08.2147

Year 2022

International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2022 (WCLC2022) – August 6-9, Vienna/Austria

  1. Behr C, Koffijberg H, IJzerman M, Kauczor HU, Revel MP, Silva M, von Stackelberg O, van Til J, Vliegenthart R
    Citizens’ willingness to participate in combination screening for lung cancer, COPD and CVD
  2. Silva M, Prosch H, Voigt W.
    Clinical scores, biomarkers and IT tools in lung cancer screening – can an integrated approach overcome current challenges?

Year 2023

International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2023 (WCLC2023) – September 9-12, Singapore

  1. Togka K, Pan X, Lancaster H, Silva M, Oudkerk M
    Cost-consequence analysis of artificial intelligence assisted image reading in lung cancer screening.
  2. Lancaster H, Heuvelmans MA, Gratama JW, Silva M, Oudkerk M
    Low-Dose CT Iterative Reconstructions can Impact Lung Nodule Measurements and Type Classification
  3. Vonder M, van der Aalst C, Hubert J, Moldovanu D, Schmitz A, Delorme S, Gratama JW, Silva M, de Koning H, Oudkerk M.
    Artificial Intelligence as Concurrent Reader in Prospective European Lung Cancer Screening (4-IN-THE-LUNG-RUN) Trial
  4. Lancaster HL, Jiang B, Gratama JW, Silva M, Heuvelmans MA, Oudkerk M.
    AI Can Greatly Reduce Radiologist Workload if Used as a First Read Filter to Rule-Out Negative Cases in Lung Cancer Screening

ESCR ESTI Joint Meeting 2023, October 26-28, Berline (DE)

  1. Gallone VI, Zilioli C, Favia P, Mura R, Leo L, Cavalieri DM, Tesse D, Ledda RE, Milanese G,  Sverzellati N, Silva M.
    Feasibility Of AI-Based Automated Reading For LungRADS Categories Assignement: 
    A Preliminary Analysis. 
  2.  

Congresses/Courses AS FACULTY: Invited SpeakerYear 2011

  1. Congresso Regionale Associazione Italiana Pneumologi Ospedalieri (AIPO) Lombardia: “La HRCT nelle patologie Ostruttive Polmonari: non solo enfisema”. October 07-08, 2011 - Milano (IT).
  2. II Raduno regionale del Gruppo SIRM Emiliano-Romagnolo: “Interstiziopatie Diffuse”. November 18, 2011 - Bologna (IT).

 

Year 2012        

  1. Simpòsio Brasil-Itàlia, Mòdulo Pneumologia: Avaliação radiológica, Session of Interstitial Lung Diseases. May 9-11, 2012 - Parma (IT).
  2. Integrazione Ospedale-Territorio, “Ipertensione polmonare - Percorso Diagnostico Terapeutico”. September 27, 2012 - Parma (IT)

Year 2014

  1. Corso Avanzato di HRCT. April 9-11 and May 14-16, 2014 - Parma (IT).
  2. HERMES National Summer School 2014 (European Respiratory Society). July 7-10, 2014 - Milan (IT).
  3. 4th International Thoracic Oncology Congress Dresden (ITOCD 4), September 12-14, 2014 - Dresden (DE).
  4. HRCT delle malattie polmonari diffuse. Sezione di Radiologia Toracica, Società Italiana di Radiologia Medica (SIRM). October 10, 2014 - Trento (IT).
  5. TC ad Alta Risoluzione del Torace. Sezione di Radiologia Toracica, Società Italiana di Radiologia Medica (SIRM). November 14, 2014 - Roma (IT).

Year 2015

  1. Thoracic Surgery Part I – European Association of Cardio-Thoracic Surgery (EACTS) : “Screening for Lung Cancer and Sleeve Resections”. April 13-17, 2015 – Windsor (UK)
  2. IV Congresso Nazionale AIMAR - 8th International Conference on Management & Rehabilitation of Chronic Respiratory Failure: “L’ Imaging in Oncologia Polmonare”. May 6-9, 2015 – Pescara (IT)
  3. Joint Meeting European Society of Thoracic Imaging (ESTI) and Fleischner Society.  “Parametric response maps: A new clinical tool for imaging?”. June 4-6, 2015 – Barcelona (ES)
  4. Euroregional Conference on Thoracic Oncology: “Lung Cancer Screening by Spiral CT”. June 12-13, 2015 - Vilnius (LT)
  5. Convegno Nazionale della Sezione di Radiologia Toracica della SIRM; Sessione “Broncopneumopatia Cronica Ostruttiva: Focus sulla Patologia Ostruttiva delle Piccole Vie Aeree” : Diagnostica per Immagini per la “Daily Practice” . September 16-18, 2015 – Parma (IT). 
  6. Corso di Formazione Teorico-Pratico dell’Associazione Italiana Pneumologi Ospedalieri (AIPO) - Tubercolosi: Emergenza Sanitaria Globale. “Aspetti Radiologici della Malattia Tubercolare”. October 8-9, 2015 – Parma (IT).
  7. HRCT delle malattie polmonari diffuse. Sezione di Radiologia Toracica, Società Italiana di Radiologia Medica (SIRM). October 9-10, 2015 - Rovereto (IT).
  8. Thoracic Imaging - European Respiratory Society (ERS) : “Mediastinum” 22-24 October, 2015 – Barcelona (E)  

Year 2016

  1. PneumoTrieste 2016: “Lo screening del tumore polmonare: siamo pronti?”. April 11-13, 2016 – Trieste (IT). 
  2. Congresso della Sezione Regionale AIPO Emilia Romagna, Sessione “Coinvolgimento Polmonare nelle Patologie Reumatologiche”, April 20, 2016 – Modena (IT)
  3. Corso AIPO – V Post Graduate Course “LE PNEUMOPATIE INTERSTIZIALI DIFFUSE | PID |”, April 28-30, 2016 – Gubbio (IT)
  4. 19th WCBIP/WCBE World Congress - Joint Meeting of the World Association for Bronchology and Interventional Pulmonology and the International Bronchoesophagological Society, May 8-11, 2016 – Florence (IT)
  5. “International Symposium on: COPD” organized by the University of Florence, June 23-25, 2016 – Florence (IT)
  6. XVII Congresso Nazionale della Pneumologia, Session “Imaging Toracico”, Lecture: “Sistemi di quantificazione delle malattie infiltrative diffuse” AND Session “Screening del tumore del polmone mediante TC toracico a bassa dose: mito o realtà?”, Lecture “Indicazioni sullo screening”, October 5-7, 2016 – Milan (IT)
  7. Corso di Formazione Teorico-Pratico dell’Associazione Italiana Pneumologi Ospedalieri (AIPO) - Tubercolosi: Emergenza Sanitaria Globale. “Aspetti Radiologici della Malattia Tubercolare”. October 20-21, 2016 – Parma (IT)
  8. IV HERMES National School, Lecture “Lung Imaging”, November 28-Decemeber 1, 2016 – Milan (IT)

Year 2017

  1. Course “Diffuse Lung Diseases: a Multidisciplinary Approach”, Lecture “Nodular pattern on HRCT”, January 20, 2017 – Bologna (IT).
  2. ECR 2017 (European Congress of Radiology) – Session (RC 1204): “Thoracic manifestations of systemic disease”, Lecture: “Systemic sclerosis”, March 1-5 (European Congress of Radiology) - Vienna, Austria.
  3. 6th AIR Meeting Italia, Session “Interactive Workshop on Fibrotic Lung Diseases – Multidisciplinary Clinical Challenge”, March 31-April1, 2017 – Bologna (IT).
  4. Convegno Nazionale della Sezione di Radiologia Toracica della SIRM, Session “Lo screening del tumore polmonare”, Lecture “Linee guida e raccomandazioni internazionali a confronto” – September 14-16, 2017 – Rome (IT). 
  5. Course “Aspetti pratici di gestione dell’immunoterapia nella pratica clinica: fra PDL1, tossicità endocrinologica e pseudo-progressione”, Lecture “Imaging in corso di immunoterapia”, September 18, 2017 – Parma (IT).
  6. Course “Master in Asma Bronchiale”, Lecture “Imaging dell’asma grave e della rinosinusite”, September 29-30, 2017 – Garbagnate Milanese (IT).
  7. Course “Master Class di Radiologia”, Lecture “Il CAD nelle malattie diffuse polmonari”, October 9-10, 2017 – Parma (IT).
  8. Course “Imaging Oncologico Polmonare”, Lecture “Screening”, October 17, 2017 – Bologna (IT) 
  9. Congress “Tosse e dispnea nella pratica clinica”, Lecture “Ruolo dell’imaging nella dispnea”, November 17-18, 2017 – Parma (IT).

Year 2018

  1. ECR 2018 (European Congress of Radiology) – E3 - ECR Academies – Topic 18 “Chest Imaging” – E3 118: “Lung cancer in the era of molecular oncology and immune therapy”, Lecture: “ALK-rearranged lung adenocarcinomas”, February 28-March 4 (European Congress of Radiology) - Vienna, Austria.
  2. Società Italiana di Radiologia Medica (SIRM): Course “Il nodulo polmonare: aggiornamenti nella diagnosi e nel management” – Sessione “La gestione del nodulo polmonare”, Lecture “Il nodulo polmonare: aggiornamenti nella diagnosi e nel management”, March 22, 2017 – Istituto Europeo Oncologico, Rozzano (MI), Italy.
  3. Course: “Il percorso del paziente con NSCLC avanzato con l’avvento dell’immunoterapia in I linea: difficolta e soluzioni nella pratica clinica quotidiana” – Session “Il percorso del paziente nella fase terapeutica”, Lecture” “Il momento della rivalutazione di malattia”, March 27, 2018 – Parma (IT).
  4. 99th Deutscher Röntgenkongress. Session “International Image Interpretation Quiz”, May 11, 2018 – Leipzig, Germany.
  5. Joint Meeting of European Society of Thoracic Imaging (ESTI) and European Society of Cardiovascular Radiology (ESCR), Session “COPD”, Lecture "Imaging work up in Lung Volume Reduction surgery", May 24-26 – Geneva, Switzerland.
  6. Course “Dibattito sulle Interstiiopatie Polmonari Fibrosanti”, Lecture “Imaging: Nuove Acquisizioni per la Corretta Interpretazione del Pattern Radiologico”, October 19-20, 2018 – Napoli (IT).
  7. Thoracic Imaging - European Respiratory Society (ERS), Lecture “Mediastinum” 25-27 October, 2018 – Barcelona (E) 
  8. Congresso Nazionale SIRM 2018 (Societa Italiana di Radiologia Medica); Lecture: “Modulazione della dose negli studi TC del torace: fino a che punto ci possiamo spingere?”. November 08-11, 2018 – Genova, Italy
  9. Course “Brixia 2018: Una giornata sull’Imaging del polmone”, Session “Il nodulo polmonare: solido, parzialmente solido e ground-glass”, Lecture “Imaging radiologico del nodulo parzialmente solido e ground-glass”, December 3, 2018 – Brescia (IT).
  10. Course “Brixia 2018: Una giornata sull’Imaging del polmone”, Session “Interstiziopatie fibrosanti: III parte (casistica ragionata)”, December 3, 2018 – Brescia (IT).
  11. Course “HRCT del torace: dalla tecnica alla refertazione”, Session “Focus sulle patologie fibrosanti del polmone”, Lecture “L’IPF e il rischio di tumore polmonare”, December 14-15, 2018 – Palermo (IT)

Year 2019

  1. Course “Le malattie polmonari diffuse fibrosanti” – Lecture: “Tecniche di Quantificazione”. January 25, 2019 – Milan (IT)
  2. ECR 2019 (European Congress of Radiology) 
    • POSTGRADUATE EDUCATIONAL PROGRAMME – Multidisciplinary Session (MS1): ”Lung Cance Team”, Lecture: “Imaging and staging”, February 27-March 3 (European Congress of Radiology) - Vienna, Austria
    • E3 - ECR Academies – Topic 18 “Chest Imaging” – E3 118: “Lung cancer in the era of molecular oncology and immune therapy”, Lecture: “ALK-rearranged and others mutations of lung adenocarcinomas”, February 27-March 3 (European Congress of Radiology) - Vienna, Austria
  3. Joint Meeting European Society of Thoracic Imaging (ESTI) and Fleischner Society.  Pre-congress Workshop, Session: “High Resolution CT”, Lecture: “GGO opaciLes and consolidaLon”. May 8, 2019 – Paris (FR)
  4. Joint Meeting European Society of Thoracic Imaging (ESTI) and Fleischner Society.  Session: “CT Lung Cancer Screening”, Lecture: “Risk models and biomarkers: Do they improve screening?”. May 9-11, 2019 – Paris (FR)
  5. International Associationf for the Study of Lung Cancer (IASLC) World Congress on Lung Cancer (WCLC) – September 7-10, Barcelona. 
    Pre-congress Workshop:
    • Session: “ Next Gen Imaging for Lung Cancer Screening How Do We Get There?”, Lecture: “Group Discussion with Interactive Questions”
    • Session “Functional Imaging Issues with Screening”, Lecture: “Experience with Imaging Platform Consistency”

Pre-congress Symposium: 

  • Session: “Global Prospective on Evolving Issues with CT Imaging in Lung Cancer Screening Populations”, Lecture: “Application of updated Fleischner Society Guidelines for Management of Lung Nodules”
  1. Symposium “NELSON, MILD und Co: Neue Erkenntnisse zum Lungenscreening”, Lecture “MILD, BioMILD results and further prospective” . October 24, 2019 – Universitätsspital Zürich (CH)

Year 2020

  1. Netherlands Heart Days 2020. Session 3 ”Lung Nodule Detection and Characterization”, Lecture “Baseline Nodules in Lung Cancer Screening”. January 16-18, 2020 – Nieuwpoort, Curaçao.
  2. Scandinavian MDCT course – Januar 22-24, 2020 in Larvik, Norway. 
    Lectures:
    • “Lung cancer: radiological management of advanced disease and radiological opportunities for early diagnosis”
    • “Smoking related lung diseases and radiological differential in dyspnea”
  3. Course: “PROGETTO PRIMATO. L’inquadramento del clinico e il contributo del radiologo su: BPCO, infezioni polmonari, interstiziopatie, noduli polmonari” – Lecture: “Il nodulo polmonare: facile rivelarlo... ma come gestirlo? Un aiuto dello screening”. January 23-25, 2020 – Milan 
  4. ECR 2020 (European Congress of Radiology) –  Session “NH 16 - Lung cancer screening implementation in Europe: is it inevitable?”, Lecture: “Lung cancer screening in Europe”, July 15-19 (European Congress of Radiology) – Online
  5. Webinar della Sezione di Radiologia Toracica della SIRM, Session"Lo screening del tumore polmonare: a che punto siamo?", Lecture: “Screening del tumore polmonare: evidenze dai trials “, September 14 – Online 
  6. Course: “Maratona di Pratica Clinica Respiratoria: 1° ROUND”, Session: “Modulo 4: Imaging”, Lecture: “Nodulo polmonare: facile rilevarlo...ma come gestirlo? Un aiuto dallo screening”, September 14-18 – Online
  7. Congresso Nazionale SIRM 2020 (Societa Italiana di Radiologia Medica); Session: “Deep learning – Il tumore polmonare: stato dell'arte e nuove prospettive”, Lecture: “Screening del tumore del polmone: pronti per partire?”. October 1-2 – Online and Rimini, Italy
  8. ECR 2020 Highlight Weeks: “Highlight Week Cardiovascular/Chest” September 29-30, 2020 – Online
    • Session: “C 19 - Structured reporting: how to provide the key information - application to thoracic imaging”, Lecture “Pulmonary nodules in lung cancer screening”
    • Session: “ESTI - Lung nodule management: case-based session”, Lecture “Solid nodule measurement, follow-up and criteria of positive screens”
    • Session: “Live Session: Chest”, Panelist.
  9. Journées Francophones de Radiologie Diagnostique & Interventionnelle – Medical Imaging International Congress, October 2-5 – Online and Paris, France
    • Session: “Management of the first wave of the COVID-19 epidemic, country experiences”, Lecture: “Expérience italienne”
    • Session in French: “Faire face à la pandémie de COVID-19 : évaluation internationale de la réponse de l'imagerie”, Lecture in French: “Réponse de l'imagerie dans la pandémie COVID en Italie”
  10. Prevent Cancer Foundation “Quantitative Imaging Workshop XVII: Leveraging CT to Accelerate Detection of Lung Cancer, COPD and Cardiovascular Disease”, Panelist in the Session: “Making Progress Toward a COPD & Small Lung Nodule Protocol”, October 29 – Online 
    ( https://web.cvent.com/event/465f1a7c-bf28-4ad8-829a-567b91870a43/summary )
  11. Webinar: “Pneumodicina 2020”, Session “Radiologia”, Lecture “Approccio quantitativo nelle malattie fibrosanti polmonari” – November 23, 2020 – Online and Milan, Italy
  12. European Society of Thoracic Imaging (ESTI) – Winter Course.  Session: “COVID and infection”, Lecture: “Thoracic Imaging in COVID-19”. December 10, 2020 – Online and Tromso, Norway
  13. Webinar: “Integrate 3.0 - Update sul trattamento del NSCLC in Stadio III”, Session “MODULO III - Valutazione della risposta e survivorship” – December 17, 2020 – Online and Genova, Italy
    • Lecture: “Valutazione della risposta al trattamento combinato”
    • Lecture: “Quale follow up dopo trattamento integrato?”

Year 2021

  1. ECR 2021 (European Congress of Radiology) –  Session “E3 919 - Low-dose thoracic CT: only screening for lung cancer?”, Lecture: “Overview of lung cancer screening activities in European countries”, March 3-7, 2021 – Online
  2. Case-based webinars della Sezione di Radiologia Toracica – Session “I Management del Nodulo Polmonare nella Pratica Clinica: Revisione di casistica”, Lecture “Nodulo Subsolido” – May 17, Online
  3. “NSCLS on Stage” – Lecture “Ruolo dell’Imaging Stadiativo”, April 28 and May 21, 2021 – Online
  4. IASLC 2021 CT Screening Symposium (International Association for the Study of Lung Cancer) – Session “Topic 3: Lung Cancer Screening implementation methodology”, Lecture: “Reconstruction protocols software vendor performance”, May 7-8, 2021 – Online
  5. Progetto SEGNO: La Semeiotica clinica e l’imaGiNg delle patOlogie respiratorie – Session “L’imaging toracico”, Lecture “Il nodulo polmonare: facile rilevarlo..ma come gestirlo? Un aiuto dallo screening” – September 9-10, Napoli
  6. International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2021 (WCLC2021). Session: “Screening and Early Detection in Lung Cancer”, Lecture: “Future Directions: Screening and AI” – September 8-14 – Online
  7. La Diagnosi Precoce del Tumore Polmonare Tramite TC a Bassa Dose: il Progetto PEOPLHE, Session “La Diagnosi Precoce del Tumore Polmonare”, Lecture “Il Nodulo Polmonare” – October 2, Catania
  8. Congresso Congiunto delle Sezioni di Radiologia Toracica, Radioprotezione e Radiobiologia con il Gruppo Regionale SIRM Lombardia.
    Convegno Nazionale della Sezione di Radiologia Toracica – Session “Screening del Tumore Polmonare”, Lecture “I risultati dei trials dell’ultimo decennio” – October 8-9, Milan
  9. Maratona di Pratica Clinica Respiratoria: 2o Round. Session: “L’Imaging del Torace: Le Patologie Respiratorie Sotto la Lente”, Session “Il nodulo polmonare: facile rilevarlo..ma come gestirlo? Un aiuto dallo screening” – October 7-10, Viareggio
  10. Quantitative Imaging Workshop XVIII: Optimizing Thoracic Imaging to Detect and Manage Early Lung Cancer and COPD (Prevent Cancer Foundation) – Session “Lung Cancer & Copd Imaging – Technical Imaging Guidance”, Lecture “Improving CT Lung Cancer Screening Through Image Quality Optimization” – November 4-5, Online
  11. European Society of Thoracic Imaging, Section of Lung Cancer Screening: Workshop “Hands-on” for the sue of computer aided detection for volume segmentation of lung nodules – October 13, Online
    Role: Master Tutor

Year 2022

  1. Italian Network for Education in Residency Program – Series “Emergencies”, Seminar no 8 “Dyspnoea”. March 8, 2022 – Online 
  2. Pneumomedicina 2022, Session “Hot topics in radiologia toracica”, Lecture “ILA (Interstitial lung abnormalities)”. May 26-28, 2022, Milan/Italy
  3. 28th Annual Scientific Meeting of the European Society of Thoracic Imaging (ESTI) – Session “Screening”, Lecture “3 challenges – Lessions learned from Italy”. June 09-11, Oxford/United Kingdom
  4. 28th Annual Scientific Meeting of the European Society of Thoracic Imaging (ESTI) – Session “Lung Nodule”, Lecture “Incidental nodules: How to reduce over diagnosis and investigation?”. June 09-11, Oxford/United Kingdom
  5. European Respiratory Society (ERS) Research Seminar “Time to move forward: Challenges and Research Opportunities for Lung Cancer Screening and Early Detection in Europe” – Session “Session 3: The world does not stand still: evolution in diagnosis and treatment”, Lecture “Is ultra-low-dose ready for practice?”. June 23-24, 2022, Lisbon/Portugal.
  6. ECR 2022 (European Congress of Radiology) –  Session “E³ - Advanced Course: Lung, Mediastinum and Pleural Imaging – Subsolid lung nodules: the integrated approach”, Lecture: “When to intervene”, July 14-17, Vienna/Austria
  7. XXI CONGRESSO NAZIONALE della Società Italiana di Endoscopia Toracica (SIET) – Session “Early Stage / Screening”, Lecture “Indeterminate And Collateral Findings: Hand Guide And Optimized Management”. September 29 – October 1, Rome/Italy
  8. Prevent Cancer Foundation “Quantitative Imaging Workshop XIX: Utilizing Quantitative Thoracic Imaging to Optimize Population Health”, Panelist in the Session: “Session Five: Exploring New Ct Imaging & Artificial Intelligence Technical Opportunities”, Introdoctury Lecture “New CT Technologies: Opportunities and Challenges”, November 4 – Online

Year 2023

  1. ECR 2023 (European Congress of Radiology) – March 1 – 5, Vienna (Austria)
    • Oncologic Imaging (ETC Level: LEVEL II+III) – Session “E3 25B –Lung cancer screening (LCS): a newcomer to the game”, Lecture “Who should be screened, how and at which intervals?” – March 2, 2023
    • Chest, Imaging Methods (ETC Level: LEVEL I+II) – Session “BS 20b – Thorax: all you need to know in daily clinical hospital practice”, Lecture “Tips and tricks about pulmonary nodules” – March 4, 2023
  2. 44th International Conference On Screening For Lung Cancer & 12th Conference On Research For Early Lung Cancer Treatment – June 28-30, Verona (Italy) and Online (Hybrid meeting format)
    • Panel discussion “Expanding the Role of Nodule Volumetric - Role of Nodule Volumetric”
    • Session “Technology updates”, Lecture “Minimizing Radiation Exposure”
  3. ESCR ESTI Joint Meeting 2023, Session “Masterkurs Thorax –LCS II: Implementation”, Lecture “LCS in Europe”. October 26-28, Berline (DE)
  4. 1° Congresso Nazionale AITeRTC, Session “TC Polmonare”, Lecture “I vari programmi di screening del tumore polmonare”. November 3-4, Parma (IT)
  5. MAMMELLA-TORACE Espandiamo l’orizzonte - Convegno Nazionale Congiunto delle Sezioni di Studio di Senologia e Radiologia Toracica con la partecipazione della Sezione di Studio dei Mezzi di Contrasto, Session “Screening Carcinoma Mammario e Polmonare”, Lecture “Criticità dello screening carcinoma polmonare: adesione ai round di screening ed alla gestione dei reperti indeterminate” – November 8-11, Torino (IT)
  6. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: ““Solid nodule measurement and follow‐up, criteria of positive screen”. December 11, 2023 – Online

 

Congresses/Courses AS FACULTY: ModeratorYear 2015

  1. Joint Meeting European Society of Thoracic Imaging (ESTI) and Fleischner Society.  Session” Controversies in thoracic oncology”. June 4-6, 2015 – Barcelona (ES).
  2. HRCT delle malattie polmonari diffuse. Sezione di Radiologia Toracica, Società Italiana di Radiologia Medica (SIRM). October 9-10, 2015 - Rovereto (IT).

Year 2016

  1. ECR 2016, March 2-6 (European Congress of Radiology) - Vienna, Austria. Moderator in the Scientific Session “SS 604 (Topic: Chest): Spectral CT, nodules, fibrosis and emphysema”.

Year 2017

  1. 4th World Congress of Thoracic Imaging (WCTI), Session “Quantitative, Emphysema, Infection”, June 18-21 – Boston (MA), USA.
  2. Associazione Italiana Pneumologi Ospedalieri (AIPO): Course “Tubercolosi, da stop TB a end TB”, Session “Aspeti Clinici e Diagnostici”, November 9 – Parma (IT). 

Year 2018

  1. Società Italiana di Radiologia Medica (SIRM): Course “Il nodulo polmonare: aggiornamenti nella diagnosi e nel management” – Sessione “Il nodulo polmonare: oltre limaging radiologico”, Invited lecture “Il nodulo polmonare: aggiornamenti nella diagnosi e nel management”, March 22, 2017 – Istituto Europeo Oncologico, Rozzano (MI), Italy
  2. Checklist di refertazione dell’imaging testa-collo, May 4 2018 – Parma, Italy
  3. Joint Meeting of European Society of Thoracic Imaging (ESTI) and European Society of Cardiovascular Radiology (ESCR), Scientific Session "Lung cancer", May 24-26 – Geneva, Switzerland.
  4. Congresso Nazionale SIRM 2018 (Societa Italiana di Radiologia Medica); Scientific Session: “Miscellanea”. November 08-11, 2018 – Genova, Italy

Year 2019

  1. ECR 2019, February 28 – March 3 (European Congress of Radiology) - Vienna, Austria. Moderator in the Refresh Course (RC 504) “Pulmonary neuroendocrine proliferations and neoplasms” within the Postgraduate Educational Programme. 
  2. European Respiratory Society (ERS) International Congress 2019 Madrid IFEMA, Spain, 28 September – 2 October 2019. Session: “Lung Cancer Grand Round”

Year 2020

  1. Netherlands Heart Days 2020, January 16-18 – Nieuwpoort, Curaçao. Moderator in “Session 5 – B3 Hot Topics” in Lung Cancer Screening (Speakers: Oudkerk M, Baldwin DR, Vliegenthart R).
  2. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “Solid nodule measurement and follow up criteria for positive screens”. December 14, 2020 – Online

Year 2021

  1. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “Subsolid nodules evaluation and follow‐up, criteria of positive screens”. January 18, 2021 – Online
  2. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “How to evaluate the coronary arteries and management of ancillary findings”. February 22, 2021 – Online
  3. European Respiratory Society (ERS) International Congress 2021.
    Session: “Imaging in COVID-19”. September 5-8, 2021 – Online
  4. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “An overview of LCS: A summary of the main trial results from ELCAP to NELSON”. September 13, 2021 – Online
  5. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “Solid nodule morphological evaluation: How to recognise obviously benign/malignant nodules, how to recognise intrapulmonary lymph nodes, pitfalls”. November 15, 2021 – Online
  6. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “Solid nodule measurement and follow‐up, criteria of positive screen”. December 5, 2021 – Online
  7. European Society of Thoracic Imaging (ESTI) – Winter Course. Session “Nodules and lung cancer screening” – December 9-10, Online

Year 2022

  1. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “Subsolid nodules evaluation and follow‐up, criteria of positive screens”. January 31, 2022 – Online
  2. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “How to evaluate the coronary arteries and management of ancillary findings”. February 21, 2022 – Online
  3. European Society of Thoracic Imaging (ESTI), Webinar “Interstitial Lung Disease- the Multidisciplinary role of the Radiologist”. March 21, 2022 – Online
  4. “MDD perfetto”issued by the Unit of Pulmonology of the University Hospital of Parma, Session 2 “Talk Show_Sharing Experience”. March 18, 2022
  5. 28th Annual Scientific Meeting of the European Society of Thoracic Imaging (ESTI) – Session “Screening”. June 09-11, Oxford/United Kingdom
  6. International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2022 (WCLC2022), Session “ES01 - Implementation and Continuous Optimization of Lung Cancer Screening”.  August 6-9, Vienna/Austria
  7. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “An overview of LCS: A summary of the main trial results, from ELCAP to NELSON”. September 19, 2022 – Online
  8. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: “Solid nodule morphological evaluation: How to recognise obviously benign/malignant nodules, how to recognise intrapulmonary lymph nodes, pitfalls”. November 7, 2022 – Online
  9. Lung Cancer Screening Certification Program issued by European Society of Thoracic Imaging (ESTI).  Webinar: ““Solid nodule measurement and follow‐up, criteria of positive screen”. December 5, 2022 – Online

Year 2023

  1. ECR 2023 (European Congress of Radiology) – March 1 – 5, Vienna (Austria)
    • Scienfitic Session “RPS 2204 - Thoracic imaging in COVID-19” – March 5, 2023

Congresses/Courses AS FACULTY: Scientific CommitteeYear 2018

  1. European Congress of Radiology (ECR) 2018, February 28-March 4, Vienna/Austria
    Member of the Scientific Subcommittee "Chest".

Year 2019

  1. European Congress of Radiology (ECR) 2019 February 27-March 3, Vienna/Austria
    Member of the Scientific Subcommittee "Chest".

Year 2020

  1. European Congress of Radiology (ECR) 2020 March 11-15, Vienna/Austria
    Member of the Scientific Subcommittee "Chest".

Year 2021

  1. International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2021 (WCLC2021) September 8-14 – Online
    Invited Abstract Reviewer (March 26, 2021)

Year 2022

  1. International Association for the Study of Lung Cancer (IASLC) – World Congress of Lung Cancer 2022 (WCLC2022) August 6-9, Vienna/Austria
    Chair for the “Early Detection and Screening” track
     

_ _ _ _ _ _ _

 

Updated January 2024

Da Lunedì a Venerdì, su appuntamento

Anno accademico di erogazione: 2024/2025

Anno accademico di erogazione: 2023/2024

Anno accademico di erogazione: 2022/2023

Anno accademico di erogazione: 2021/2022

Anno accademico di erogazione: 2020/2021

Anno accademico di erogazione: 2019/2020

Anno accademico di erogazione: 2018/2019

Anno accademico di erogazione: 2017/2018

Anno accademico di erogazione: 2016/2017

Docente tutor

Linee di ricerca

Thoracic Imaging --- Lung Cancer Screening by Low-Dose Computed Tomography --- Radiomics

Pubblicazioni

  • Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
    Anno: 2024
    Autore/i: Balbi Maurizio, Mazzaschi Giulia, Leo Ludovica, Moron Dalla Tor Lucas, Milanese Gianluca, Marrocchio Cristina, Silva Mario, Mura Rebecca, Favia Pasquale, Bocchialini Giovanni, Trentini Francesca, Minari Roberta, Ampollini Luca, Quaini Federico, Roti Giovanni, Tiseo Marcello, Sverzellati Nicola
  • Study rationale and design of the PEOPLHE trial
    Anno: 2024
    Autore/i: Milanese G., Silva M., Ledda R. E., Iezzi E., Bortolotto C., Mauro L. A., Valentini A., Reali L., Bottinelli O. M., Ilardi A., Basile A., Palmucci S., Preda L., Sverzellati N., Aliotta L., Barbarino S., Borzi S., Casotto V., Catalano M., Cavalieri D. M., Clemenza M., Contino M., Crimi L., Curia B., Favia P., Gallone V. I., Guicciardi G., La Rosa G., Leo L., Mura R., Priore A., Ruongo L., Scavone C., Zilioli C.
  • High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study
    Anno: 2024
    Autore/i: Desai S. R., Sivarasan N., Johannson K. A., George P. M., Culver D. A., Devaraj A., Lynch D. A., Milne D., Renzoni E., Nunes H., Sverzellati N., Spagnolo P., Baughman R. P., Yadav R., Piciucchi S., Walsh S. L. F., Kouranos V., Wells A. U., Anderson A., Morgenthau A., Gaser A., Vizel A., Speranskaya A., Gerke A., Goksel A., Undurraga A., Sharma A., Oh A., Leung A., Larici A. R., Prasse A., Mazzei A., Morais A., Bhalla A., Del Rio B., Jankharia B., Elicker B., Pereira C., Biegelman-Aubry C., White C., Ravaglia C., Hsia C., Schaefer-Prokop C., Launay D., Talwar D., Castillo D., Patel D., Israel-Biet D., Valeyre D., Britt E. J., Bargagli E., Bendstrup E., Crouser E., Nossent E., Shmelev E., Porquera E. C., Bonella F., Cohen-Aubart F., Jeny F., Ferrara G., Jin G. Y., Robbie H., Prosch H., Sumikawa H., Ling-Pei H., Lee H. Y., Strambu I., Buendia-Roldan I., Grutters J., Ryu J., Swigris J., Miedema J., Goo J. M., Barnett J., Verschakelen J., Goldin J., Seo J. B., Enghelmayer J., Mana J., Behr J., Patterson K., Antoniou K., Brown K., Fujimoto K., Savale L., Maier L., Richeldi L., Neto M. L. R., Humbert M., Judson M., Veltkamp M., Wilsher M., Molina M., Otaola M., Revel M. -P., Silva M., Drent M., Schiebler M., Wijsenbeek-Lourens M., Bonifazi M., Remy-Jardin M., Koslow M., Balter M., Kreuter M., Thillai M., Hamzeh N., Chaudhuri N., Mogulkoc N., Todd N., Screaton N., Goh N., Shah N., Obi O., Shlobin O., Baranova O., Bresser P., Rottoli P., Brillet P. -Y., Said-Hartley Q., Borie R., Mostard R., van Zyl-smit R., Kairalla R., Egashira R., Boussouar S., Lee S. M., Bhalla S., Tomassetti S., Quadrelli S., Hart S. P., Danoff S., Rajan S., Choi S. M., Copley S., Kim T. J., Johkoh T., Corte T., Mcloud T., Wessendorf T., Alfaro T., Arai T., Costabel U., Vicens-Zygmunt V., Poletti V., Cottin V., Vucinic V., Wuyts W., van Es W., Jeong Y. J., Inoue Y.
  • Willingness to participate in combination screening for lung cancer, chronic obstructive pulmonary disease and cardiovascular disease in four European countries
    Anno: 2024
    Autore/i: Behr C., Koffijberg H., Ijzerman M., Kauczor H. U., Revel M. P., Silva M., von Stackelberg O., van Til J., Vliegenthart R.
  • Airway Diseases in Geriatric Patients
    Anno: 2023
    Autore/i: Balbi M., Ledda R. E., Pamparino S., Milanese G., Silva M., Sverzellati N.
Lista completa pubblicazioni

Orcid

https://orcid.org/0000-0002-2538-7032

Altro

Clinical activity at Unit "Scienze Radiologiche", with specific focus on thoracic disease

Clinical activity at Unit "Radiologia di Emergenza-Urgenza", with specific focus on emergency

Radiology staff at the multidisciplinary meetings of "Oncology" and "Thoracic disease"

Contatti

Ubicazione dell'ufficio

Scienze Radiologiche, Pad. Barbieri, Ospedale Universitario di Parma

Via Gramsci 14

43126, Parma (IT)